Nanopharmaceuticals: Principles And Applications Vol. 2
V. K. Yata, Shivendu Ranjan, N. Dasgupta, Eric Lichtfouse
Published 2020 ·
Download PDFAnalyze on Scholarcy
Over the last couple of years, several studies have been communicated to endorse the tremendous potential of nanopharmaceuticals for the welfare of human beings and other living organisms. However, very limited concepts have been realized in the form of final products. There are various factors which are responsible for the inadequate development of nanopharmaceuticals such as inherent faults of nanocarrier; implausible absorption, distribution, metabolism, excretion/eliminaP. Verma Department of Biotechnology, Bansal Institute of Engineering and Technology, Lucknow, Uttar Pradesh, India J. K. Ratan (*) Department of Chemical Engineering, Dr. B. R. Ambedkar National Institute of Technology Jalandhar, Jalandhar, Punjab, India e-mail: firstname.lastname@example.org
This paper references
Enhancement of stability and skin permeation by sucrose stearate and cyclodextrins in progesterone nanoemulsions.
V. Klang (2010)
Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art
S. Rai (2017)
Nanopharmaceuticals (part 2): products in the pipeline
V. Weissig (2015)
Nano-labelled cells-a functional tool in biomedical applications.
E. Naumenko (2014)
Medicinal weeds of crop fields and role of women in rural health and hygiene in Nalbari district, Assam
Dk Bhattacharjya (2008)
Preliminary Results of Nanopharmaceuticals Used in the Radioimmunotherapy of Ovarian Cancer
S. McQuarrie (2004)
Recent advances and future prospects of phyto-phospholipid complexation technique for improving pharmacokinetic profile of plant actives.
J. Khan (2013)
Interaction of liposome formulations with human skin in vitro.
G. Betz (2001)
Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing
Rafal Kamiński (2016)
Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance.
M. Creixell (2012)
The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance.
A. Selen (2014)
Nanotechnology: What it can do for drug delivery.
K. Park (2007)
Preparation and nanoencapsulation of l-asparaginase II in chitosan-tripolyphosphate nanoparticles and in vitro release study
E. Bahreini (2014)
Transdermal Delivery of Ondansetron Hydrochloride via Bilosomal Systems: In Vitro, Ex Vivo, and In Vivo Characterization Studies
H. Ammar (2018)
Synergistic rheological behaviour of mixed HM/LM pectin gels
C. Löfgren (2007)
Hyaluronidase-Sensitive Nanoparticle Templates for Triggered Release of HIV/AIDS Microbicide In Vitro
Vivek Agrahari (2013)
Encapsulation and release of hydrophobic bioactive components in nanoemulsion-based delivery systems: impact of physical form on quercetin bioaccessibility.
Hector Pool (2013)
Vesicular system: Versatile carrier for transdermal delivery of bioactives
D. Singh (2015)
Environmental Protection Agency: Pharmaceuticals and Personal Care Products Drug Disposal and Stewardship (2010) Ramifications for the Environment and Human Health
Critical evaluation and methodological positioning of the transdermal microdialysis technique. A review.
F. Erdő (2016)
Microfluidic methods for forming liposomes.
Dirk van Swaay (2013)
Topical Delivery of Fenoprofen Calcium via Elastic Nano-vesicular Spanlastics: Optimization Using Experimental Design and In Vivo Evaluation
D. Farghaly (2017)
Investigation of the apoptotic way induced by digallic acid in human lymphoblastoid TK6 cells
W. Bhouri (2011)
Use of various vegetable oils in designing photoprotective nanostructured formulations for UV protection and antioxidant activity
G. Badea (2015)
Advances and new technologies applied in controlled drug delivery system
F. Bassyouni (2013)
D Heber (2011)
Acute inflammation. A Rev
G Ryan (1977)
Penetration of metallic nanoparticles in human full-thickness skin.
B. Baroli (2007)
Surrogate cells or Trojan horses. The discovery of liposomes.
A. Bangham (1995)
Portfolio Management in New Drug Development
M. Ding (2014)
A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation: an in vivo study.
B. Godin (2005)
Dendronized heparin-doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy.
Wenchuan She (2013)
Transfersomal Nanoparticles for Enhanced Transdermal Delivery of Clindamycin
Ahmed A. H. Abdellatif (2015)
Improved anti-melanoma effect of a transdermal mitoxantrone ethosome gel.
X. Yu (2015)
Extraction, isolation and characterization of bioactive compounds from plants' extracts.
S. Sasidharan (2011)
Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy
J. E. Chung (2014)
M cells in the follicle-associated epithelium of the rabbit conjunctiva preferentially bind and translocate latex beads.
Hongshan Liu (2005)
DOXIL when combined with Withaferin A (WFA) targets ALDH1 positive cancer stem cells in ovarian cancer.
S. Kakar (2016)
The use of nano-quercetin to arrest mitochondrial damage and MMP-9 upregulation during prevention of gastric inflammation induced by ethanol in rat.
Somsuta Chakraborty (2012)
Optimization protocol for the extraction of 6-gingerol and 6-shogaol from Zingiber officinale var. rubrum Theilade and improving antioxidant and anticancer activity using response surface methodology
A. Ghasemzadeh (2015)
Nanomedicine(s) under the microscope.
R. Duncan (2011)
Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/ conventional angiography suite--initial experience with four patients.
M. Wilson (2004)
Challenges in Development of Nanoparticle-Based Therapeutics
N. Desai (2012)
Nanoparticles for imaging: top or flop?
F. Kiessling (2014)
Non‐covalent formulation of active principles with dendrimers: Current state‐of‐the‐art and prospects for further development
I. El’kin (2017)
Safranal-loaded solid lipid nanoparticles: evaluation of sunscreen and moisturizing potential for topical applications
B. Khameneh (2015)
Potential New Methods for Antiepileptic Drug Delivery
R. Fisher (2002)
Biological impact assessment of nanomaterial used in nanomedicine. Introduction to the NanoTEST project
L. Juillerat-Jeanneret (2015)
Thin-film hydration preparation method and stability test of DOX-loaded disulfide-linked polyethylene glycol 5000-lysine-di-tocopherol succinate nanomicelles
Xiaoyu Ai (2014)
Project on Emerging Nanotechnologies
Linda K. Breggin (2007)
Adverse effects of citrate/gold nanoparticles on human dermal fibroblasts.
N. Pernodet (2006)
Nanoparticles in cancer therapy and diagnosis.
I. Brigger (2002)
Liposomes and nanotechnology in drug development: focus on ocular targets
M. Honda (2013)
Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
W. Cheng (2008)
Nanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue Targeting
B. C. Palmer (2016)
Preparation of mixed monoterpenes edge activated PEGylated transfersomes to improve the in vivo transdermal delivery efficiency of sinomenine hydrochloride.
J. Wang (2017)
Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne
T. Garg (2016)
Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target
E. Golia (2014)
Experimental treatment of breast cancer-bearing BALB/c mice by artemisinin and transferrin-loaded magnetic nanoliposomes
A. Gharib (2015)
Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin.
G. Cevc (1998)
Dextran-functionalized magnetic fluid mediating magnetohyperthermia for treatment of Ehrlich-solid-tumor-bearing mice: toxicological and histopathological evaluations
A. L. Miranda-Vilela (2013)
Cubosome formulations stabilized by a dansyl-conjugated block copolymer for possible nanomedicine applications.
S. Murgia (2015)
Enhanced skin permeation of a lipophilic drug using supersaturated formulations.
K. Moser (2001)
Effect of pegylation on pharmaceuticals
J. Harris (2003)
Optimization of surface chemistry on single-walled carbon nanotubes for in vivo photothermal ablation of tumors.
X. Liu (2011)
Perspectives on dendritic architectures and their biological applications: From core to cell.
V. Viswanath (2017)
Normal Cutaneous Wound Healing: Clinical Correlation with Cellular and Molecular Events
C. Baum (2005)
PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery.
P. Milla (2012)
Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage.
Y. Pan (2009)
Improving on Nature: The Role of Nanomedicine in the Development of Clinical Natural Drugs.
A. Bilia (2017)
Targeted gene delivery of polyethyleneimine-grafted chitosan with RGD dendrimer peptide in αvβ3 integrin-overexpressing tumor cells.
Young-Min Kim (2017)
Therapeutics and carriers: the dual role of proteins in nanoparticles for ocular delivery.
S. Pescina (2015)
Ethanol effects on the gelation behavior of α-tocopherol acetate-encapsulated ethosomes with water-soluble polymers
Chun Wei Chiu (2012)
Conventional and Dense Gas Techniques for the Production of Liposomes: A Review
Louise A. Meure (2008)
Liposomes for protein delivery: selecting manufacture and development processes.
A. Weiner (1994)
Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration.
G. E. El Maghraby (2000)
Advances and challenges in smart and functional polymer vesicles
J. Du (2009)
Lymphatic targeting of zidovudine using surface-engineered liposomes.
C. D. Kaur (2008)
Turning Theory into Practice: The Development of Modern Transdermal Drug Delivery Systems and Future Trends
O. Perumal (2013)
Discovery and resupply of pharmacologically active plant-derived natural products: A review
A. Atanasov (2015)
Cysteine-induced modifications of zero-valent silver nanomaterials: implications for particle surface chemistry, aggregation, dissolution, and silver speciation.
Andreas P. Gondikas (2012)
Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101.
Sonke Svenson (2011)
Magnetic nanoparticle design for medical diagnosis and therapy
S. Mornet (2004)
Commentary on the draft revised guideline on the environmental risk assessment of medicinal products for human use
R. Whomsley (2019)
Assessment of simvastatin niosomes for pediatric transdermal drug delivery
A. Zidan (2016)
Preparation and evaluation of niosome gel containing acyclovir for enhanced dermal deposition
Shery Jacob (2017)
Feasibility of drug delivery to the eye's posterior segment by topical instillation of PLGA nanoparticles
Kohei Tahara (2017)
Using modeling to help understand vaginal microbicide functionality and create better products
D. Katz (2011)
Selection of aptamers with high affinity and high specificity against C595, an anti-MUC1 IgG3 monoclonal antibody, for antibody targeting.
S. Missailidis (2005)
Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility
M. Durán-Lobato (2016)
Physicochemical and Pharmacokinetic Parameters in Drug Selection and Loading for Transdermal Drug Delivery
N. S. Chandrashekar (2008)
Permeation Enhancers for Transdermal Drug Delivery
V. Sinha (2000)
Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer.
J. Gallo (2013)
Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene
Y. Mo (2007)
Transdermal drug delivery: penetration enhancement techniques.
H. Benson (2005)
Treating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristine
T. Davis (2013)
Role of Polyphenols and Other Phytochemicals on Molecular Signaling
S. Upadhyay (2015)
Clinical Translation of Nanomedicine.
Y. Min (2015)
Application of Nanotechnology in Pharmaceutical Formulation Design and Development
Ram S. Thakur and Ruchi Agrawal (2015)
Polymers and nanoparticles: intelligent tools for intracellular targeting?
M. Breunig (2008)
Formulation and characterization of norethisterone transdermal patch as an alternative route to oral administration
Ü. Gönüllü (2018)
Search term: SLIT cisplatin
Chapter 23 – Rice Bran Oil: Benefits to Health and Applications in Pharmaceutical Formulations
L. A. Rigo (2014)
Therapeutic potential of chitosan
M M Safhi (2016)
The role of anticancer activity of sesquiterpene lactones
K Gach (2015)
Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention.
S. Rocha (2011)
Cyclodextrin-Based Nanosponges for Delivery of Resveratrol: In Vitro Characterisation, Stability, Cytotoxicity and Permeation Study
K. A. Ansari (2011)
Therapeutic Potential of Natural Product-Based Oral Nanomedicines for Stroke Prevention
Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin.
M. Takahashi (2009)
Investigating superiority of novel bilosomes over niosomes in the transdermal delivery of diacerein: in vitro characterization, ex vivo permeation and in vivo skin deposition study
D. Aziz (2019)
Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy.
M. Moreno-Sastre (2015)
Doxorubicin-conjugated PEGylated dendrimers show similar tumoricidal activity but lower systemic toxicity when compared to PEGylated liposome and solution formulations in mouse and rat tumor models.
L. M. Kaminskas (2012)
Effect of liposomes and niosomes on skin permeation of enoxacin.
J. Fang (2001)
Skin delivery of oestradiol from lipid vesicles: importance of liposome structure.
G. E. El Maghraby (2000)
Nanoparticles for Herbal Extracts
Vani Mamillapalli (2016)
Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactively labelled vesicles.
M. Fresta (1996)
Doxorubicin-loaded liposomes: enhancing the oral bioavailability by modulation of physicochemical characteristics.
Marjan Daeihamed (2017)
A novel one-pot 'green' synthesis of stable silver nanoparticles using soluble starch.
N. Vigneshwaran (2006)
Drug Delivery Systems: Entering the Mainstream
T. Allen (2004)
Large volume liposomes by an ether vaporization method.
D. Deamer (1976)
Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats.
T. Allen (1983)
Optimization, in vitro cytotoxicity and penetration capability of deformable nanovesicles of paclitaxel for dermal chemotherapy in Kaposi sarcoma
K. Pathak (2016)
Recent progress in dendrimer-based nanocarriers.
Shuhua Bai (2006)
The big picture on nanomedicine: the state of investigational and approved nanomedicine products.
M. Etheridge (2013)
Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy
Nupur Parnami (2014)
A pharmacokinetic overview of nanotechnology-based drug delivery systems: an ADME-oriented approach.
M. Hamidi (2013)
Phytosterols improve immunity and exert anti-inflammatory activity in weaned piglets.
Q. Hu (2017)
Advances in combination therapy of lung cancer: Rationales, delivery technologies and dosage regimens
L. Wu (2017)
Risk Assessment and Risk Minimization in Nanomedicine: A Need for Predictive, Alternative, and 3Rs Strategies
L. Accomasso (2018)
TOPICAL REVIEW: Progress in applications of magnetic nanoparticles in biomedicine
Q. Pankhurst (2009)
The drug delivery field at the inflection point: Time to fight its way out of the egg
K. Park (2017)
Gemcitabine-loaded albumin nanospheres (GEM-ANPs) inhibit PANC-1 cells in vitro and in vivo
J. Li (2013)
Modulation of glutathione and its dependent enzymes in gill cells of Anguilla anguilla exposed to silica coated iron oxide nanoparticles with or without mercury co-exposure under in vitro condition.
K. Srikanth (2014)
Reshaping the future of nanopharmaceuticals: ad iudicium.
S. Moghimi (2011)
Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin.
V. Kakkar (2011)
Tumor delivery of macromolecular drugs based on the EPR effect.
V. Torchilin (2011)
Fabrication and evaluation of the novel reductionsensitive starch nanoparticles for controlled drug release
J Yang (2014)
BCS class IV drugs: Highly notorious candidates for formulation development
R. Ghadi (2017)
Cytotoxic constituents from Andrographis paniculata induce cell cycle arrest in jurkat cells.
Madamanchi Geethangili (2008)
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma.
B. Ruozi (2010)
Patented and Approval Scenario of Nanopharmaceuticals with Relevancy to Biomedical Application, Manufacturing Procedure and Safety Aspects.
V. Agarwal (2018)
Quercetin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer
X. Guan (2016)
Inflammation and cancer: advances and new agents
S. Crusz (2015)
Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes.
D. C. Litzinger (1994)
Formulation and Pharmacokinetics of Thermosensitive Stealth® Liposomes Encapsulating 5-Fluorouracil
Chantal Al Sabbagh (2014)
Formulation, characterization and pharmacokinetics of Morin hydrate niosomes prepared from various non-ionic surfactants.
Ayman Yahia Waddad (2013)
A Functional Iron Oxide Nanoparticles Modified with PLA-PEG-DG as Tumor-Targeted MRI Contrast Agent
F. Xiong (2017)
Paclitaxel: What has been done and the challenges remain ahead.
E. Bernabeu (2017)
Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers.
D. Paolino (2005)
Liposome surface charge influence on skin penetration behaviour.
A. Gillet (2011)
Treatment of cutaneous candidiasis through fluconazole encapsulated cubosomes
Vijay Prajapati (2014)
The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model
I. Debergh (2010)
Liposomes--a selective drug delivery system for the topical route of administration: gel dosage form.
M. Mezei (1982)
Applications of novel drug delivery system for herbal formulations.
Nanotechnology Approaches for Ocular Drug Delivery
Qingguo Xu (2013)
Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties.
S. Moghimi (2003)
Nanomedicine: promises and challenges for the future of public health
Michelle Pautler (2010)
Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.
P. Pradhan (2010)
Magnetic nanoparticles as gene delivery agents: enhanced transfection in the presence of oscillating magnet arrays.
S C McBain (2008)
Non-invasive administration of drugs through the skin: challenges in delivery system design.
Starch: Application of biopolymer in random lasing
Konrad Cyprych (2014)
Dendrimer-conjugated iron oxide nanoparticles as stimuli-responsive drug carriers for thermally-activated chemotherapy of cancer.
Saumya Nigam (2017)
The influence of solid lipid nanoparticles on skin hydration and viscoelasticity--in vivo study.
S. Wissing (2003)
Excellent antiproliferative and pro-apoptotic effects of ( − ) -epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo
I A Siddiqui (2014)
Polymeric nanoparticles for colon cancer therapy: overview and perspectives.
Xinru You (2016)
Effect of ion pairing with alkylamines on the in-vitro dermal penetration and local tissue disposition of salicylates.
S. A. Megwa (2000)
Essential oils encapsulated in liposomes: a review
Mirna Sherry (2013)
Fate of micelles and quantum dots in cells.
D. Maysinger (2007)
Clinical advances of nanocarrier-based cancer therapy and diagnostics
E. Luque-Michel (2017)
Polyethyleneimine-based core-shell nanogels: a promising siRNA carrier for argininosuccinate synthetase mRNA knockdown in HeLa cells.
H. Mimi (2012)
Interaction of phosphatidylcholine liposomes with the human stratum corneum.
S. Zellmer (1995)
AS1411 Aptamer-Anionic Linear Globular Dendrimer G2-Iohexol Selective Nano-Theranostics
P. Mohammadzadeh (2017)
Microfluidic directed formation of liposomes of controlled size.
A. Jahn (2007)
Colloidal phytosterols: synthesis, characterization and bioaccessibility
L. Rossi (2010)
Ethosomes : A Novel Vesicular Carrier For Enhanced Transdermal Delivery Of An AntiHIV Agent
S. Jain (2004)
Polymersomes: A Synthetic Biological Approach to Encapsulation and Delivery
M. Massignani (2010)
Mucoadhesive and thermogelling systems for vaginal drug delivery.
C. Caramella (2015)
Liposomes and skin: from drug delivery to model membranes.
G. E. El Maghraby (2008)
Recent advances in the molecular design of synthetic vaccines.
L. Jones (2015)
Diffusion of univalent ions across the lamellae of swollen phospholipids.
A. Bangham (1965)
In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin.
A. Pardakhty (2007)
Studies of diffusion of water through dead human skin; the effect of different environmental states and of chemical alterations of the epidermis.
G. Berenson (1951)
Adverse Events with Biomedicines: Prevention Through Understanding
G. Tridente (2013)
Nanomedicine – prospective therapeutic and diagnostic applications
D. Emerich (2005)
Proniosomes as a novel drug carrier system for buccal delivery of benzocaine
S. H. A. El-Alim (2014)
Predicting antimicrobial peptides from eukaryotic genomes: In silico strategies to develop antibiotics
A. C. Amaral (2012)
Studies on pectin coating of liposomes for drug delivery.
S. Nguyen (2011)
Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier.
B. Godin (2004)
Particle size of liposomes influences dermal delivery of substances into skin.
D. Verma (2003)
Toxicological assessment of orally delivered nanoparticulate insulin
C. Reis (2008)
The effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of guinea pig in vitro. 2. The effects of the hydrophobic group in phospholipids and a comparison with general enhancers
Yuichi Yokomizo (1996)
Biocompatibility of chitosan-coated iron oxide nanoparticles with osteoblast cells
Si-Feng Shi (2012)
Aerodynamics and deposition effects of inhaled submicron drug aerosol in airway diseases.
Md Faiyazuddin (2013)
TPGS-modified liposomes for the delivery of ginsenoside compound K against non-small cell lung cancer: formulation design and its evaluation in vitro and in vivo.
L. Yang (2016)
Anthocyanins are bioavailable in humans following an acute dose of cranberry juice.
P. Milbury (2010)
The application of nanoemulsion in dermatology: an overview
Y. Wu (2013)
Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration.
A. Amrite (2005)
Sunscreen Penetration of Human Skin and Related Keratinocyte Toxicity after Topical Application
C. Hayden (2005)
Transdermal Drug Delivery
P. Uzor (2012)
Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans
A. Naik (1995)
Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers
Fengling Wang (2017)
Iontophoretic delivery of peptide drugs
P. G. Green (1996)
Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery.
R. Mainardes (2006)
Confocal Raman microscopy and multivariate statistical analysis for determination of different penetration abilities of caffeine and propylene glycol applied simultaneously in a mixture on porcine skin ex vivo.
Saul Mujica Ascencio (2016)
Design and optimization of 20-O-linked camptothecin glycoconjugates as anticancer agents.
H. Lerchen (2001)
Preparation of Lipid Nanoemulsions Incorporating Curcumin for Cancer Therapy
S. Anuchapreeda (2012)
Global cancer facts and figures
Nanoformulation of natural products for prevention and therapy of prostate cancer.
V. Sanna (2013)
Common peptide epitopes in glycophorin and the endothelial sialoglycoprotein gp60.
J. Schnitzer (1992)
Formation of artificial multicompartment vesosome and dendrosome as prospected drug and gene delivery carriers.
C. Paleos (2013)
Natural products: a continuing source of novel drug leads.
G. Cragg (2013)
Focused ultrasound influence on calcein-loaded thermosensitive stealth liposomes
A. Novell (2015)
Silver nanoparticles: green synthesis and their antimicrobial activities.
V. Sharma (2009)
Effects of mitomycin C and porfiromycin on exponentially growing and plateau phase cultures
S. Rockwell (1994)
Chapter 2: Nanoliposomes: preparation and analysis
M R Mozafari (2010)
Anticancer activity of resveratrolloaded gelatin nanoparticles on NCI-H460 non-small cell lung cancer cells
S Karthikeyan (2013)
An in vitro and in vivo study of gemcitabineloaded albumin nanoparticles in a pancreatic cancer cell line
X Yu (2015)
Nanotechnologies -vocabulary -Part 2: Nano-objects. International Organization for Standardization
Nanopharmaceuticals for drug delivery: a review
R Bawa (2009)
Dendrimer internalization and intracellular trafficking in living cells.
L. Albertazzi (2010)
Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
M. El-Ridy (2018)
Towards the Fabrication of Polyelectrolyte-Based Nanocapsules for Bio-Medical Applications
L. Pastorino (2016)
In vitro and in vivo evaluation of Δ⁹-tetrahidrocannabinol/PLGA nanoparticles for cancer chemotherapy.
L. Martín-Banderas (2015)
Micro-scale devices for transdermal drug delivery.
A. Arora (2008)
Phytosomes loaded with mitomycin C-soybean phosphatidylcholine complex developed for drug delivery.
Z. Hou (2013)
Stabilized nanoparticles of phytosterol by rapid expansion from supercritical solution into aqueous solution
M. Türk (2008)
Antiangiogenic Properties of Gold Nanoparticles
Priyabrata Mukherjee (2005)
Nanoparticle-based targeted drug delivery.
R. Singh (2009)
Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues.
M. Foldvari (2008)
Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery
L. E. V. Vlerken (2007)
The Pharmaceutical Industry: Specificity, Challenges, and What You Can Learn from this Book
M. Ding (2014)
Nano-niosomes as nanoscale drug delivery systems: an illustrated review.
Saeid Moghassemi (2014)
Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects
S. Prabhu (2012)
Iron oxide nanoparticles for sustained delivery of anticancer agents.
Tapan Jain (2005)
Chronic exposure of tilapia (Oreochromis niloticus) to iron oxide nanoparticles: Effects of particle morphology on accumulation, elimination, hematology and immune responses.
M. Ates (2016)
The nanomedicine revolution: part 3: regulatory and safety challenges.
C. Ventola (2012)
Recent Advances in Lipid-Based Vesicles and Particulate Carriers for Topical and Transdermal Application.
Shashank Jain (2017)
Basics and recent advances in peptide and protein drug delivery.
Benjamin J. Bruno (2013)
Formulation and characterization of polyphenol-loaded lipid nanocapsules.
A. Barras (2009)
Anticancer Potentials of Root Extract of Polygala senega and Its PLGA Nanoparticles-Encapsulated Form
S. Paul (2011)
Transdermal Delivery of Interferon Alpha-2B using Microporation and Iontophoresis in Hairless Rats
A. Badkar (2007)
DNA nanovehicles and the biological barriers.
A. Okholm (2016)
Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance
E. Perez (2009)
Nanoparticle vesicular systems : A versatile tool for drug delivery
S. Verma (2010)
The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.
S. Gelperina (2005)
Ecotoxicological impact of engineered nanomaterials in bivalve molluscs: An overview.
T. Rocha (2015)
Enhanced transdermal delivery of an anti-HIV agent via ethanolic liposomes.
V. Dubey (2010)
Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
Mohd Qumbar (2017)
Artemisinin nanoformulation suitable for intravenous injection: Preparation, characterization and antimalarial activities.
N. Ibrahim (2015)
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine.
Xue-Qing Zhang (2012)
Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
A. AlKilany (2010)
Heparin based nanoparticles for cancer targeting and noninvasive imaging.
M. Nurunnabi (2012)
Iron oxide nanoparticles to an Indian major carp, Labeo rohita: impacts on hematology, ion regulation and gill Na+/K+ ATPase activity
A M Ribeiro (2015)
Proteinnanoparticle interactions: opportunities and challenges
M Mahmoudi (2011)
Nanoparticles and the immune system.
Banu S. Zolnik (2010)
Hydration and percutaneous absorption: I. Influence of hydration on alkanol permeation through hairless mouse skin.
C. R. Behl (1980)
Influence of cholesterol on liposome stability and on in vitro drug release
Maria-Lucia Briuglia (2015)
Dual-Prevention for UV-Induced Skin Damage: Incorporation of Melatonin-Loaded Elastic Niosomes into Octyl Methoxycinnamate Pickering Emulsions
Gulcin Arslan Azizoglu (2017)
Microfluidic-Enabled Liposomes Elucidate Size-Dependent Transdermal Transport
R. R. Hood (2014)
Development strategies and biopharmaceutical aspects of drug delivery systems
N. Demina (2013)
Skin permeation behavior of elastic liposomes: role of formulation ingredients
J. Chen (2013)
Nanomedicine: Application of Nanobiotechnology in Medical Practice
K. Jain (2008)
Preparation and Evaluation of Imiquimod Loaded Liposomal Dispersion: Part-I
Tanmay N. Patel (2013)
From ecotoxicology to nanoecotoxicology.
A. Kahru (2010)
A review of the application of lipid-based systems in systemic, dermal/ transdermal, and ocular drug delivery.
P. Gershkovich (2008)
Advanced Drug Delivery Systems of Curcumin for Cancer Chemoprevention
Shyam S. Bansal (2011)
PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides
Yongzhuo Huang (2008)
Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
A. Abdelbary (2015)
Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles.
P. Ramalingam (2016)
Photostability and ex-vivo permeation studies on diclofenac in topical niosomal formulations.
G. Ioele (2015)
Acute toxicity and pharmacokinetics of 13 nm-sized PEGcoated gold nanoparticles
W S Cho (2009)
Clinical comparison between paclitaxel liposome (Lipusu(R)) and paclitaxel for treatment of patients with metastatic gastric cancer
X Xu (2013)
Evolutionary approaches for drug and gene delivery by micro and nano magnetic carriers. Indo-global
T Garg (2012)
The Role of Inflammation in Cardiovascular Outcome
F. Montecucco (2017)
A brief review on the application of nanoparticle enclosed herbal medicine for the treatment of infective endocarditis.
M. Namdari (2017)
Applications of nanomaterials in food packaging with a consideration of opportunities for developing countries
E. Bradley (2011)
Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs.
P. Sharma (2010)
Nanoethosomes for transdermal delivery of tropisetron HCl: multi-factorial predictive modeling, characterization, and ex vivo skin permeation
Hanaa A Abdel Messih (2017)
Decreased stratum corneum cerarnides in atopic individuals—a pathobiochemical factor in xerosis?
B. Melnik (1988)
Selection of high efficient transdermal lipid vesicle for curcumin skin delivery.
Yingzheng Zhao (2013)
Novel Long-Circulating Lipid Nanocapsules
D. Hoarau (2004)
Polymer-associated liposomes for the oral delivery of grape pomace extract.
M. Manconi (2016)
In situ preparation of magnetic chitosan/Fe3O4 composite nanoparticles in tiny pools of water-in-oil microemulsion
J. Zhi (2006)
Multifunctional Magnetic Liposomes for Cancer Imaging and Therapeutic Applications
Manashjit Gogoi (2016)
Paclitaxel/epigallocatechin gallate coloaded liposome: a synergistic delivery to control the invasiveness of MDA-MB-231 breast cancer cells.
Satiesh kumar Ramadass (2015)
Paclitaxel poliglumex for ovarian cancer
V. Galic (2011)
Mechanism of taxane neurotoxicity
Hiroki Hagiwara (2004)
Nanopharmaceuticals for improved topical vaginal therapy: can they deliver?
Željka Vanić (2013)
The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles.
Dar-Shih Hsieh (2011)
Identifying present challenges to reliable future transdermal drug delivery products.
S. A. Giannos (2015)
Magnetic nanoparticles for drug delivery
J. Dobson (2006)
Polymeric nanoparticles for targeted treatment in oncology: current insights
R. Prabhu (2015)
Pharmaceutical Lifecycle Extension Strategies
E. Kappe (2014)
Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery.
Ghada M El Zaafarany (2010)
Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes
Erika Dosekova (2017)
Current state on the development of nanoparticles for use against bacterial gastrointestinal pathogens. Focus on chitosan nanoparticles loaded with phenolic compounds.
A. R. Madureira (2015)
NOVEL DRUG DELIVERY SYSTEM IN HERBAL'S
Kharat Amol (2014)
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer.
W. Gradishar (2005)
Liposomes--a selective drug delivery system for the topical route of administration. Lotion dosage form.
M. Mezei (1980)
Permeability of the skin.
R. Scheuplein (1971)
Increased Loading, Efficacy and Sustained Release of Silibinin, a Poorly Soluble Drug Using Hydrophobically-Modified Chitosan Nanoparticles for Enhanced Delivery of Anticancer Drug Delivery Systems
Cha Yee Kuen (2017)
Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy.
Indranil Banerjee (2016)
Investigation of the mechanism of flux across human skin in vitro by quantitative structure-permeability relationships.
M. Cronin (1999)
Development and characterization of protein loaded poly-lactideco-glycolide nanospheres
M D Blanco (1997)
In vitro antioxidant properties of the diterpenes Parvifloron D and 7α-acetoxy-6β-hydroxyroyleanone
S Rosa (2015)
Anticancer properties of Allium sativum -a review
R Ranjani (2012)
Nanopharmaceuticals (part 1): products on the market
V. Weissig (2014)
How can lipid nanocarriers improve transdermal delivery of olanzapine?
N. Iqbal (2017)
Nanotechnologies for biomolecular detection and medical diagnostics.
M. Cheng (2006)
Triple function nanocomposites of porous silica-CoFe2O4-MWCNTs as a carrier for pH-sensitive anti-cancer drug controlled delivery.
Huitao Fan (2017)
Ethosomes Loaded with Cryptotanshinone for Acne Treatment through Topical Gel Formulation
Zhenwei Yu (2016)
Some anticancer medicinal plants of foreign origin
S. Madhuri (2009)
Drug-Metabolizing Enzymes in the Skin of Man, Rat, and Pig
F. Oesch (2007)
Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.
X. Dong (2010)
The zerovalent iron nanoparticle causes higher developmental toxicity than its oxidation products in early life stages of medaka fish.
Pei-jen Chen (2013)
Modulation of the Barrier Function of the Skin
J. Hadgraft (2001)
PULSATILE DRUG DELIVERY SYSTEMS: PULSINCAP SYSTEM
T. Garg (2012)
Encapsulation of cannabinoid drugs in nanostructured lipid carriers.
E. Esposito (2016)
Synthesis, characterization, anti-bacterial, anti-fungal and nematicidal activities of 2-amino-3-cyanochromenes.
Muhammad Nawaz (2016)
Electrical and physical methods of skin penetration enhancement
J. Grice (2012)
Different biokinetics of nanomedicines linking to their toxicity; an overview
Sara Mostafalou (2013)
Redox biology of Leishmania and macrophage targeted nanoparticles for therapy.
H. S. Sarwar (2017)
Clinical prospects for liposomes.
M. Yatvin (1982)
Thermodynamic analysis of the effect of cholesterol on dipalmitoylphosphatidylcholine lipid membranes.
W. Bennett (2009)
Preparation of a ligustrazine ethosome patch and its evaluation in vitro and in vivo
Xingyan Liu (2011)
Tenfibgen Ligand Nanoencapsulation Delivers Bi-Functional Anti-CK2 RNAi Oligomer to Key Sites for Prostate Cancer Targeting Using Human Xenograft Tumors in Mice
J. H. Trembley (2014)
Phytocannabinoids as novel therapeutic agents in CNS disorders.
A. Hill (2012)
Feasibility of proniosomes-based transdermal delivery of frusemide: formulation optimization and pharmacotechnical evaluation.
A. Azeem (2008)
Anti-proliferative activity of silver nanoparticles
P. Asharani (2009)
Functional nanogels for biomedical applications.
M. Asadian-Birjand (2012)
Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations
H. Abdelkader (2014)
Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam.
A. M. Al-mahallawi (2015)
Doxorubicin: nanotechnological overviews from bench to bedside.
Maximiliano Cagel (2017)
Nanocrystal Preparation: Low-Energy Precipitation Method Revisited
Shahzeb Khan (2013)
Integrated assessment of toxic effects of maghemite (γ-Fe2O3) nanoparticles in zebrafish.
R. A. Villacis (2017)
Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
F. Alexis (2008)
Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen.
M. M. Elsayed (2007)
Bioavailability and Delivery of Nutraceuticals and Functional Foods Using Nanotechnology
H. Yu (2013)
Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate).
C. Passirani (1998)
Phase II Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients with Advanced Pancreatic Cancer
M. Saif (2010)
Effects of nanomaterials on marine invertebrates.
L. Canesi (2016)
Pathophysiology of Acute Pancreatitis
R. Schmid (2005)
Evaluation of paeonol‐loaded transethosomes as transdermal delivery carriers
Z. Chen (2017)
Inflammation in neurodegenerative diseases--an update.
S. Amor (2014)
Biopharmaceutical classification system: A strategic tool for oral drug delivery technology
N. K. Sachan (2009)
Lipid vesicles for skin delivery of drugs: reviewing three decades of research.
M. M. Elsayed (2007)
Hafnium oxide nanoparticles: toward an in vitro predictive biological effect?
Julie Marill (2014)
Vesicular carriers for dermal drug delivery
C. Sinico (2009)
Influence of electronic and formulation variables on transdermal iontophoresis of tacrine hydrochloride
N. Patel (2015)
In vitro toxicity of nanoparticles in BRL 3A rat liver cells.
S. Hussain (2005)
Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials
Ibrahim M. Abdulbaqi (2016)
Regulating nanomedicine - can the FDA handle it?
R. Bawa (2011)
Optimization of methotrexate loaded niosomes by Box–Behnken design: an understanding of solvent effect and formulation variability
Ahmed S. Zidan (2017)
Synthesis, characterization, antibacterial activity and cytotoxicity of hollow TiO2-coated CeO2 nanocontainers encapsulating silver nanoparticles for controlled silver release.
Jacinthe Gagnon (2016)
Graphene and graphene oxide as new nanocarriers for drug delivery applications.
J. Liu (2013)
Advances in Brief Tea Polyphenol ( )-Epigallocatechin-3-Gallate Inhibits DNA Methyltransferase and Reactivates Methylation-Silenced Genes in Cancer Cell Lines
M. Fang (2003)
Protective Effect of Scopoletin Against Cerulein-Induced Acute Pancreatitis and Associated Lung Injury in Mice
George Leema (2018)
Herbal Cosmetics for Skin and Hair care
Virendra P. Kapoor (2005)
Docosahexaenoic acid loaded lipid nanoparticles with bactericidal activity against Helicobacter pylori.
C. L. Seabra (2017)
Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation
C. Jaafar-Maalej (2010)
Nanoparticles: pharmacological and toxicological significance
C. Medina (2007)
Influence of nanotechnology on herbal drugs: A Review
S. Ansari (2012)
Topical anti-inflammatory, gastroprotective and antioxidant effects of the essential oil of Lippia sidoides Cham. leaves.
M. B. Monteiro (2007)
Nanoparticle systems reduce systemic toxicity in cancer treatment.
H. Wang (2016)
Dendrimers: A Tool for Drug Delivery
Anirudha Malik (2012)
Direct fabrication and harvesting of direct fabrication and harvesting of monodisperse
J P Rolland (2005)
Process for the production of dispersions of lipidic droplets in water and new compositions based on same
G Vanlerberghe (1975)
280 Index Perrone
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
E. Miele (2009)
Nanopharmaceuticals as a solution to neglected diseases: Is it possible?
G. A. Islan (2017)
Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells.
Srinivas Ganta (2009)
Nanopharmaceutics: phytochemical-based controlled or sustained drug-delivery systems for cancer treatment.
R. Jeetah (2014)
Nanogel engineering for new nanobiomaterials: from chaperoning engineering to biomedical applications.
Y. Sasaki (2010)
RNAi-combined nano-chemotherapeutics to tackle resistant tumors.
Rakesh K Tekade (2016)
Nanocarriers for the delivery of active ingredients and fractions extracted from natural products used in traditional Chinese medicine (TCM).
Ying Liu (2015)
Systematic Development of Transethosomal Gel System of Piroxicam: Formulation Optimization, In Vitro Evaluation, and Ex Vivo Assessment
Varun Garg (2016)
Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparin.
Shuhua Bai (2007)
Inflammatory Regulation in Diabetes and Metabolic Dysfunction
Jixin Zhong (2017)
Quercetin conjugated superparamagnetic magnetite nanoparticles for in-vitro analysis of breast cancer cell lines for chemotherapy applications.
S. R. Kumar (2014)
Self-Assembled Cubic Liquid Crystalline Nanoparticles for Transdermal Delivery of Paeonol
J. Li (2015)
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros (2010)
Nanotechnology-based drug delivery systems and herbal medicines: a review
B. Bonifácio (2014)
Glycosylation in cancer: mechanisms and clinical implications
S. Pinho (2015)
A review on nanotized herbal drugs
A S Kumar (2015)
Toxicology perspective of nanopharmaceuticals: a critical review
M A Saiyed (2011)
Priyanshu Verma, 2-32 Public health
Nanopharmaceuticals: Healthcare Applications and Safety Evaluations
18 Penetration enhancement
Nanotechnology-based approaches in anticancer research
N. Jabir (2012)
Physicochemical characterisation of liposomes with encapsulated local anaesthetics.
M. Müller (2004)
A review of imaging techniques for systems biology
Armen Kherlopian (2008)
Biopharmaceutics classification system
H. Chavda (2010)
Phytosomes as Biocompatible Carriers of Natural Drugs.
Diogo Matias (2017)
Reparative inflammation takes charge of tissue regeneration
M. Karin (2016)
Antinutrients and Phytochemicals in Food
F. Shahidi (1997)
A theranostic nanocomposite system based on iron oxide-drug nanocages for targeted magnetic field responsive chemotherapy.
M. P. Kesavan (2018)
In vitro assessment of pharmaceutical potential of ethosomes entrapped with terbinafine hydrochloride.
Syed Ahmed Iizhar (2016)
Paclitaxel-conjugated PAMAM dendrimers adversely affect microtubule structure through two independent modes of action.
Erika N Cline (2013)
Liposomes incorporating essential oil of Brazilian cherry (Eugenia uniflora L.): Characterization of aqueous dispersions and lyophilized formulations
P. Yoshida (2010)
The complexity of nanoparticle dissolution and its importance in nanotoxicological studies.
S. Misra (2012)
Magnetocubosomes for the delivery and controlled release of therapeutics.
C. Montis (2015)
Antimicrobial activity of cream incorporated with silver nanoparticles biosynthesized from Withania somnifera
Gregory Marslin (2015)
Synthesis, nanosizing and in vitro drug release of a novel anti-HIV polymeric prodrug: chitosan-O-isopropyl-5'-O-d4T monophosphate conjugate.
L. Yang (2010)
Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes
F. Notario-Pérez (2017)
Evaluation of percutaneous absorption of naproxen from different liposomal formulations.
C. Puglia (2010)
Antioxidant and antimicrobial properties of essential oils encapsulated in zein nanoparticles prepared by liquid–liquid dispersion method
Yunpeng Wu (2012)
Are iron oxide nanoparticles safe? Current knowledge and future perspectives.
Vanessa Valdiglesias (2016)
Nano-transfersomal formulations for transdermal delivery of asenapine maleate: in vitro and in vivo performance evaluations
A. Shreya (2016)
Transdermal drug delivery and cutaneous metabolism.
R. H. Guy (1987)
Non-ionic surfactant effects on hairless mouse skin permeability characteristics.
K. Walters (1988)
The effect of beta-cyclodextrins on the permeation of diclofenac from supersaturated solutions.
M. Dias (2003)
Span® and Tween® neutral and pH-sensitive vesicles: Characterization and in vitro skin permeation
M. Carafa (2009)
Phage protein‐targeted cancer nanomedicines
V. Petrenko (2014)
Isolation of Antitumor Alkaloids from Cephalotaxus harringtonia
R. G. Powell (2002)
Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study
R. Puri (2012)
Preparation, Characterization and Applications of Liposomes: State of the Art
A. Laouini (2012)
Cancer therapy with phytochemicals: evidence from clinical studies
A. Hosseini (2015)
Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro
T. Dutta (2007)
How to improve R&D productivity: the pharmaceutical industry's grand challenge
S. Paul (2010)
In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration.
Gurinder Singh (2014)
Curcumin slows osteoarthritis progression and relieves osteoarthritis-associated pain symptoms in a post-traumatic osteoarthritis mouse model
Z. Zhang (2016)
Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo.
T. Allen (1991)
Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.
H. Amiri (2013)
The impact of nanobiotechnology on the development of new drug delivery systems.
O. Kayser (2005)
Delivery of molecular and cellular medicine to solid tumors.
Biochimica et Biophysica Acta targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells
A Sarkar (2016)
Innovative Strategies for Enhancing Topical and Transdermal Drug Delivery
Desmond I. J. Morrow (2007)
Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment.
A. Anitha (2014)
HIV compartmentalization: pathogenesis and clinical implications
J R Clarke (2000)
Protein nanoparticle: A unique system as drug delivery vehicles
M. Jahanshahi (2008)
Particle size-dependent organ distribution of gold nanoparticles after intravenous administration.
W. D. de Jong (2008)
Preparation of matrine ethosome, its percutaneous permeation in vitro and anti-inflammatory activity in vivo in rats
Zeng Zhao-wu (2009)
Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates.
Megan E Fox (2009)
Antifungal Therapy for Systemic Mycosis and the Nanobiotechnology Era: Improving Efficacy, Biodistribution and Toxicity
A. C. Souza (2017)
A review of pollutants in the sea-surface microlayer (SML): a unique habitat for marine organisms.
O. Wurl (2004)
Dual asymmetric centrifugation (DAC)--a new technique for liposome preparation.
U. Massing (2008)
Genotoxic and mutagenic assessment of iron oxide (maghemite-γ-Fe2O3) nanoparticle in the guppy Poecilia reticulata.
G. Qualhato (2017)
LIPOSOME-ENABLED SYNERGISTIC INTERACTION OF ANTIMICROBIAL AGENTS
R. Schiffelers (2002)
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study.
C. Mamot (2012)
Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route
S. Jain (2015)
Mechanism of percutaneous adsorption. I. Routes of penetration and the influence of solubility.
R. Scheuplein (1965)
Characterization and in vitro studies of the anticancer effect of oxidized carbon nanotubes functionalized with betulinic acid
J. Tan (2014)
Applications and genotoxicity of nanomaterials in the food industry
Venkatraman Manickam (2017)
Drug Delivery Systems and Combination Therapy by Using Vinca Alkaloids
Chun-Ting Lee (2015)
Clinical applications of magnetic drug targeting.
A. Lübbe (2001)
Wound Repair and Regeneration
J. M. Reinke (2012)
PAMAM-pullulan conjugates as targeted gene carriers for liver cell.
S. Askarian (2017)
Oil-in-water lecithin-based microemulsions as a potential delivery system for amphotericin B.
K. C. Pestana (2008)
Advances in lipid-based colloid systems as drug carrier for topic delivery.
Yingjie Zhai (2014)
Role of neuroinflammation in neurodegenerative diseases (Review)
W. Chen (2016)
Metal oxide nanoparticles as antimicrobial agents: a promise for the future.
A. Raghunath (2017)
Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force.
G. Cevc (1992)
Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells.
Kerri L George (2008)
Skin permeation of retinol in Tween 20-based deformable liposomes: in-vitro evaluation in human skin and keratinocyte models.
Yu-Kyoung Oh (2006)
Multi-chromatic pH-activatable 19F-MRI nanoprobes with binary ON/OFF pH transitions and chemical-shift barcodes.
Xiaonan Huang (2013)
Milestones in camptothecin research
H. Lerchen (2002)
Optimization of elastic transfersomes formulations for transdermal delivery of pentoxifylline.
Ahmed H Al Shuwaili (2016)
Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles
J. Kreuter (2004)
The new era of nanotechnology, an alternative to change cancer treatment
Ancuța Jurj (2017)
Nanodelivery of bioactive components for food applications: types of delivery systems, properties, and their effect on ADME profiles and toxicity of nanoparticles.
T. Borel (2014)
Genistein exhibits anti-cancer effects via down-regulating FoxM1 in H446 small-cell lung cancer cells
Tiantian Tian (2013)
Edible Nanoencapsulation Vehicles for Oral Delivery of Phytochemicals: A Perspective Paper.
J. Xiao (2017)
Antiproliferative activity of tea catechins associated with casein micelles, using HT29 colon cancer cells.
S. Haratifar (2014)
Challenges and opportunities in dermal/transdermal delivery.
Kalpana S. Paudel (2010)
Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications.
E. Fleige (2012)
Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages.
Huanyu Dou (2007)
Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies
S. Salah (2017)
Formulation of Niosomal Gel for Enhanced Transdermal Lopinavir Delivery and Its Comparative Evaluation with Ethosomal Gel
K. K. Patel (2012)
A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies.
R. Cristofoletti (2013)
Transfersomes—A Novel Vesicular Carrier for Enhanced Transdermal Delivery: Development, Characterization, and Performance Evaluation
S. Jain (2003)
Dendrimers: novel polymeric nanoarchitectures for solubility enhancement.
U. Gupta (2006)
Effects of permeation enhancers on flufenamic acid delivery in Ex vivo human skin by confocal Raman microscopy.
Yelena Pyatski (2016)
Effect of paclitaxel-loaded nanoparticles on the viability of human hepatocellular carcinoma HepG2 cells.
Zhi-hong Hou (2015)
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.
C. Reis (2006)
Protein-based nanoparticles: From preparation to encapsulation of active molecules.
Mohamad Tarhini (2017)
Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
A. Bhatia (2004)
Niosomes: novel sustained release nonionic stable vesicular systems--an overview.
N. B. Mahale (2012)
Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment
B. Garg (2016)
A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer.
A. Shafei (2017)
Encapsulation of essential oils in zein nanospherical particles.
N. Parris (2005)
Preparation and in vitro/in vivo evaluation of resveratrol-loaded carboxymethyl chitosan nanoparticles
Y. Zu (2016)
Pancreatic Cancer Therapy Review: From Classic Therapeutic Agents to Modern Nanotechnologies.
Ana Rebelo (2017)
The role of hair follicles in the percutaneous absorption of caffeine.
N. Otberg (2008)
Improving Efficacy, Oral Bioavailability, and Delivery of Paclitaxel Using Protein-Grafted Solid Lipid Nanoparticles.
D. Pooja (2016)
Liposomes for intravenous drug targeting: design and applications.
J. Metselaar (2002)
ORGANOGELS : ADVANCED AND NOVEL DRUG DELIVERY SYSTEM
Garg Tarun (2012)
Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.
M. Šala (2018)
Poly(lactic acid‐glycolic acid) nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis
A. C. Amaral (2010)
In situ preparation of magnetic Fe3O4-chitosan nanoparticles for lipase immobilization by cross-linking and oxidation in aqueous solution.
Yue Wu (2009)
Synthesis and characterization of noscapine loaded magnetic polymeric nanoparticles.
M. O. Abdalla (2010)
VESICLES - MECHANISM OF TRANSDERMAL PERMEATION: A REVIEW
P. Lakshmi (2012)
Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls
H. Nakamura (2015)
Dendrimer encapsulated and conjugated delivery of berberine: A novel approach mitigating toxicity and improving in vivo pharmacokinetics.
L. Gupta (2017)
Role of Metallic Nanoparticles in Vaccinology: Implications for Infectious Disease Vaccine Development
Lázaro Moreira Marques Neto (2017)
Cyclodextrins as encapsulation agents for plant bioactive compounds.
E. Pinho (2014)
Surface engineering of quantum dots for in vivo vascular imaging.
A. Jayagopal (2007)
Dual drug-loaded paclitaxel–thymoquinone nanoparticles for effective breast cancer therapy
P. Soni (2015)
Transdermal penetration enhancers: applications, limitations, and potential.
B. Finnin (1999)
Phytochemistry of Medicinal Plants
M. Saxena (1995)
A review of the environmental implications of in situ remediation by nanoscale zero valent iron (nZVI): Behavior, transport and impacts on microbial communities.
E. Lefèvre (2016)
Passive and semi-active targeting of bone marrow and leukemia cells using anionic low cholesterol liposomes
P. Tardi (2016)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.
H. Maeda (2000)
PLGA-based nanoparticles: A new paradigm in biomedical applications
Shweta R. Sharma (2016)
Nanotechnology for the biologist.
S. Mcneil (2005)
Impact of Silver Nanoparticles on Haemolysis, Platelet Function and Coagulation
J. Laloy (2014)
Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies.
H. M. El-laithy (2011)
DNA nanoparticles for ophthalmic drug delivery.
Jan Willem de Vries (2018)
Flow cytometry evaluation of in vitro cellular necrosis and apoptosis induced by silver nanoparticles.
G. Kumar (2015)
Liposome: classification, preparation, and applications
A. Akbarzadeh (2013)
Skin penetration behaviour of liposomes as a function of their composition.
A. Gillet (2011)
Role of saccharides for the freeze-thawing and freeze drying of liposome
Koichiro Miyajima (1997)
Zirconium phosphatidylcholine-based nanocapsules as an in vivo degradable drug delivery system of MAP30, a momordica anti-HIV protein.
Guo Caizhen (2015)
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
J. Silverman (2012)
In Vitro Percutaneous Permeation and Skin Accumulation of Finasteride Using Vesicular Ethosomal Carriers
Y. Rao (2008)
Novel mechanisms and devices to enable successful transdermal drug delivery.
B. Barry (2001)
Toxicity of gold nanoparticles functionalized with cationic and anionic side chains.
Catherine M Goodman (2004)
Water-soluble heparin–PTX conjugates for cancer targeting
I. Park (2010)
A fundamental investigation into the effects of eutectic formation on transmembrane transport.
S. Fiala (2010)
Dendrimers as carriers for delivery of chemotherapeutic agents.
S. Medina (2009)
BURGER'S MEDICINAL CHEMISTRY AND DRUG DISCOVERY
Manfred E. Wolff (1996)
ELASTIC VESICLES AS DRUGS CARRIERS THROUGH THE SKIN
C. Pîrvu (2010)
Nanoformulations of doxorubicin: how far have we come and where do we go from here?
I. Borišev (2018)
Synthesis of highly dispersed nanoscaled CoQ10 liposome by supercritical fluid
Shaohong Xu (2015)
Glycopolymer modified magnetic mesoporous silica nanoparticles for MR imaging and targeted drug delivery
Jinxia An (2015)
Delivery of phytochemical thymoquinone using molecular micelle modified poly(D, L lactide-co-glycolide) (PLGA) nanoparticles.
G. Ganea (2010)
Nanostructured lipid carriers (NLC): A potential delivery system for bioactive food molecules
F. Tamjidi (2013)
Physicochemical and Formulation Developability Assessment for Therapeutic Peptide Delivery—A Primer
Annette Bak (2014)
The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
R. Gandhi (2010)
Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa).
N. Chainani-Wu (2003)
Controlled‐release biodegradable nanoparticles: From preparation to vaginal applications
Beatriz Martínez-Pérez (2018)
Water-soluble dendritic unimolecular micelles: their potential as drug delivery agents.
M. Liu (2000)
Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery
N. Rapoport (2007)
Chitosan stabilized camptothecin nanoemulsions: Development, evaluation and biodistribution in preclinical breast cancer animal mode.
Subramanian Natesan (2017)
Arglabin — A new sesquiterpene lactone fromArtemisia glabella
S. Adekenov (2004)
Nanomedicine: current status and future prospects
S. Moghimi (2005)
Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine.
L. F. Brown (1997)
New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics
Si-Yuan Pan (2013)
Targeting tumor angiogenic vasculature using polymer-RGD conjugates.
A. Mitra (2005)
Effects of Flavonoids and other Polyphenols on Inflammation
R. González (2011)
Novel intravaginal nanomedicine for the targeted delivery of saquinavir to CD4+ immune cells
Sidi Yang (2013)
Emerging implications of nanotechnology on cancer diagnostics and therapeutics
A. Cuenca (2006)
Preparation of poly(lactic acid)/chitosan nanoparticles for anti-HIV drug delivery applications
Ashish Dev (2010)
Preparation of small amounts of sterile siRNA-liposomes with high entrapping efficiency by dual asymmetric centrifugation (DAC).
Markus Hirsch (2009)
A physiologically based pharmacokinetic model of organophosphate dermal absorption.
D. van der Merwe (2006)
Application of albumin-based nanoparticles in the management of cancer
Xinzhe Yu (2015)
Polymeric vesicles in biomedical applications
René P. Brinkhuis (2011)
Topical Liposomal local Anesthetics: Design, Optimization and Evaluation of Formulations
M. Foldvari (1993)
Toxicity of silver nanoparticles in biological systems: Does the complexity of biological systems matter?
R. Vazquez-Muñoz (2017)
Preparation, characterization and in vitro activities evaluation of solid lipid nanoparticles based on PEG-40 stearate for antifungal drugs vaginal delivery
R. Cassano (2016)
Niosomes as a propitious carrier for topical drug delivery
H. Hamishehkar (2013)
PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma.
Y. Jiang (2016)
Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures
Héloïse Ragelle (2017)
Transdermal iontophoretic delivery of tacrine hydrochloride: Correlation between in vitro permeation and in vivo performance in rats.
N. Patel (2016)
Progress in understanding cytomegalovirus drug resistance.
V. Emery (2001)
Improving environmental risk assessment of human pharmaceuticals.
M. Ågerstrand (2015)
Effects of plant sterol and stanol ester consumption on lipid metabolism, antioxidant status and markers of oxidative stress, endothelial function and low-grade inflammation in patients on current statin treatment
A. D. Jong (2008)
Methods for the Preparation and Manufacture of Polymeric Nanoparticles
C. Vauthier (2008)
Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes.
J. A. Harding (1997)
gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis.
J. Schnitzer (1992)
Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.
M. Masuda (2003)
Permeation enhancement of a highly lipophilic drug using supersaturated systems.
K. Moser (2001)
Biopolymer based nano-delivery systems for enhancing bioavailability of nutraceuticals
Bing Hu (2013)
Ecological nanotoxicology: integrating nanomaterial hazard considerations across the subcellular, population, community, and ecosystems levels.
P. Holden (2013)
Oral absorption of the HIV protease inhibitors: a current update.
Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nano-transfersomes for antioxidant and anti-aging effects in UV radiation induced skin damage
K. Avadhani (2017)
Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies.
G. E. El Maghraby (1999)
Formation and stability of oil-in-water nanoemulsions containing rice bran oil: in vitro and in vivo assessments
D. S. Bernardi (2011)
Ultrasound-enhanced transdermal delivery: recent advances and future challenges.
Matthias Oberli (2014)
Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds.
Pilar Rivera Gil (2010)
Immuno-targeting of nonionic surfactant vesicles to inflammation.
E. Hood (2007)
Chitosan-Based Multifunctional Platforms for Local Delivery of Therapeutics
Seong-Chul Hong (2017)
Ethosomes: new prospects in transdermal delivery.
B. Godin (2003)
Storage stability and skin permeation of vitamin C liposomes improved by pectin coating.
W. Zhou (2014)
Folic acid-conjugated liposomal vincristine for multidrug resistant cancer therapy
C. Wang (2013)
Construction of hyaluronic acid noisome as functional transdermal nanocarrier for tumor therapy.
M. Kong (2013)
Engineering of Dendrimer Surfaces to Enhance Transepithelial Transport and Reduce Cytotoxicity
R. Jevprasesphant (2004)
Niosomes from 80s to present: the state of the art.
C. Marianecci (2014)
Commercial titanium dioxide nanoparticles in both natural and synthetic water: comprehensive multidimensional testing and prediction of aggregation behavior.
S. Ottofuelling (2011)
Nanocarriers as an emerging platform for cancer therapy.
D. Peer (2007)
Radionuclide imaging of tumor xenografts in mice using a gelatinase-targeting peptide.
O. Medina (2005)
Magnetochemotherapy for cervical cancer treatment with camptothecin loaded Fe 3 O 4 functionalized b-cyclodextrin nanovehicle
M Rajan (2017)
Rational design and engineering of delivery systems for therapeutics: biomedical exercises in colloid and surface science.
K. Kostarelos (2003)
Intranasal delivery of N‐terminal modified leptin‐pluronic conjugate for treatment of obesity
Dongfen Yuan (2017)
Potential environmental implications of nano-enabled medical applications: critical review.
Indrani Mahapatra (2013)
Nanoemulsions: the properties, methods of preparation and promising applications
M. Koroleva (2012)
Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
Ahmed S. Guinedi (2005)
Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery.
Z. S. Bayindir (2010)
Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine.
C. Herzog (2009)
Characterization of proliposomes.
N. Payne (1986)
The spontaneous formation of unilamellar vesiscles
Danil D Lasic (1988)
Proniosomes as a carrier system for transdermal delivery of tenoxicam.
H. Ammar (2011)
Enhanced Permeability and Retention ( EPR ) Effect Based Tumor Targeting : The Concept , Application and Prospect
H. Yin (2014)
In vivo antifungal activity of two essential oils from Mediterranean plants against postharvest brown rot disease of peach fruit
H. S. Elshafie (2015)
Improved bioavailability of timolol maleate via transdermal transfersomal gel: Statistical optimization, characterization, and pharmacokinetic assessment
N. Morsi (2016)
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
Susan Hua (2018)
APPLICATION OF CHITOSAN MICROSPHERES AS DRUG CARRIERS : A REVIEW
Rahul S. Nair (2009)
Transdermal absorption enhancement of gel containing elastic niosomes loaded with gallic acid from Terminalia chebula galls
A. Manosroi (2011)
Safety and toxicity concerns of orally delivered nanoparticles as drug carriers
F. Araújo (2015)
Cell surface protein glycosylation in cancer.
M. N. Christiansen (2014)
Nanotechnology: an effective tool for enhancing bioavailability and bioactivity of phytomedicine.
T. Gunasekaran (2014)
Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium.
A. Manosroi (2008)
Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma.
S. Dhule (2012)
Environmental behaviour and ecotoxicity of quantum dots at various trophic levels: A review.
T. Rocha (2017)
Permeation enhancer strategies in transdermal drug delivery
Harneet Marwah (2016)
Uptake, delivery, and anticancer activity of thymoquinone nanoparticles in breast cancer cells
Isabelle Fakhoury (2016)
Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles
N. Ahmad (2018)
Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability.
Derajram M Benival (2012)
The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development.
L. Benet (2013)
A new biodegradable polymeric nanoparticle formulation containing Syzygium cumini: Phytochemical profile, antioxidant and antifungal activity and in vivo toxicity
P. R. Bitencourt (2016)
Antitumor effect and toxicity of Lipusu in rat ovarian cancer xenografts.
Liang Ye (2013)
Patents, Drug Delivery and Public Health Protection: Health Risk Management for Nanopharmaceuticals
L. Sant'Anna (2013)
Production, characterization, in vitro and ex vivo studies of babchi oil-encapsulated nanostructured solid lipid carriers produced by a hot aqueous titration method.
M. Faiyazuddin (2010)
Toxic effects of copper-based nanoparticles or compounds to lettuce (Lactuca sativa) and alfalfa (Medicago sativa).
J. Hong (2015)
Alginate/cashew gum nanoparticles for essential oil encapsulation.
Erick F de Oliveira (2014)
Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro.
C. Kirby (1980)
Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles
Tian Zhou (2018)
Liposomal encapsulated anti-cancer drugs.
R. Hofheinz (2005)
Co-encapsulation of resveratrol and curcumin in lipid-core nanocapsules improves their in vitro antioxidant effects.
K. Coradini (2014)
Effect Of Cholesterol Content And Surfactant HLB On Vesicle Properties Of Niosomes
S. Agarwal (2004)
Smart Carriers and Nanohealers: A Nanomedical Insight on Natural Polymers
S. Raveendran (2017)
Polymer nanoparticles: Preparation techniques and size-control parameters
J. D. Rao (2011)
Analysis of the toxicity of gold nano particles on the immune system: effect on dendritic cell functions
C. Villiers (2010)
Development of ethosomes with taguchi robust design-based studies for transdermal delivery of alfuzosin hydrochloride
D. Prasanthi (2012)
Nanobiotechnology: an efficient approach to drug delivery of unstable biomolecules.
A. C. Amaral (2013)
Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement
Nina Dragicevic (2015)
Biphasic magnetic nanoparticles-nanovesicle hybrids for chemotherapy and self-controlled hyperthermia.
Manashjit Gogoi (2014)
Bioconjugated quantum dots for in vivo molecular and cellular imaging.
A. Smith (2008)
Transdermal delivery of vancomycin hydrochloride using combination of nano-ethosomes and iontophoresis: in vitro and in vivo study
Magdy I Mohammed (2016)
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment.
S. Hobbs (1998)
Tumor-targeted nanomedicines: principles and practice
T Lammers (2008)
Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2021
WHO Drug Information (2016) A framework for risk-based identification of essential medicine products for local manufacturing in low-and middle-income countries
X Wang (2016)
Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes.
Avi Schroeder (2009)
Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer.
M. Green (2006)
Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone against Candida albicans yeasts and Candida biofilm
Mohammad A. Randhawa (2015)
Lipid Based Vesicular Drug Delivery Systems
S. Jain (2014)
In vitro and in vivo analysis of the antithrombotic and toxicological profile of new antiplatelets N-acylhydrazone derivatives and development of nanosystems: determination of novel NAH derivatives antiplatelet and nanotechnological approach.
Plínio C. Sathler (2014)
Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines
P. Calvo (2004)
Nanomedicine applications in the treatment of breast cancer: current state of the art
D. Wu (2017)
Nanoemulsion: an advanced mode of drug delivery system
Manjit Jaiswal (2014)
The abietane diterpenoid parvifloron D from Plectranthus ecklonii is a potent apoptotic inducer in human leukemia cells.
O. Burmistrova (2015)
Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity.
E. E. Connor (2005)
Antiinflammatory Effect of Phytosterols in Experimental Murine Colitis Model: Prevention, Induction, Remission Study
R. Aldini (2014)
Herbal medicine as inducers of apoptosis in cancer treatment.
E. Safarzadeh (2014)
PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.
I. Majoros (2006)
Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers.
P. Kolhe (2003)
Proliposomes as an intranasal dosage form for the sustained delivery of propranolol
Byung-Nak Ahn (1995)
Clinical Potential of Quantum Dots
A. M. Iga (2007)
A review on phospholipids and their main applications in drug delivery systems
Jing Li (2015)
Liposomes and Niosomes as Topical Drug Delivery Systems
M. J. Choi (2005)
Nanotechnology combined therapy: tyrosine kinase‐bound gold nanorod and laser thermal ablation produce a synergistic higher treatment response of renal cell carcinoma in a murine model
J. Liu (2017)
A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery.
Y. Namiki (2009)
Long-circulating and target-specific nanoparticles: theory to practice.
S. Moghimi (2001)
Injectable block copolymer hydrogels for sustained release of a PEGylated drug.
Lin Yu (2008)
Zinc phthalocyanine-loaded PLGA biodegradable nanoparticles for photodynamic therapy in tumor-bearing mice
M. Fadel (2009)
Adsorption and desorption of curcumin by poly(vinyl) alcohol-multiwalled carbon nanotubes (PVA-MWCNT)
Nurliyana Ahmad Zawawi (2017)
Testosterone Ethosomes for Enhanced Transdermal Delivery
D. Ainbinder (2005)
[Pharmacological and pharmaceutical foundation of nanodrugs].
I. Chekman (2010)
Albumin-Bound Paclitaxel: The Benefit of This New Formulation in the Treatment of Various Cancers
M. Montana (2011)
Protective effects of chitosan against the hazardous effects of zinc oxide nanoparticle in freshwater crustaceans Ceriodaphnia cornuta and Moina micrura
S. Vijayakumar (2016)
Nanosystems for Skin Delivery: From Drugs to Cosmetics.
A. F. Antunes (2017)
Ethinylestradiol-loaded ultraflexible liposomes: pharmacokinetics and pharmacodynamics.
M. Garg (2006)
Ufasomes: A vesicular drug delivery
Dasharath M. Patel (2011)
Nanodiagnostics: application of nanotechnology in molecular diagnostics
K. Jain (2003)
The price of innovation: new estimates of drug development costs.
J. DiMasi (2003)
Cationic niosomes as gene carriers: preparation and cellular uptake in vitro.
Y. Z. Huang (2005)
Nanostructures as promising tools for delivery of antimicrobial peptides.
A. Brandelli (2012)
Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.
T. Andresen (2005)
Applications of pectin: a multipurpose biomolecule
K Muruci De Paula (2016)
The Project on Emerging Nanotechnologies. Health and fitness
Thiol-modified chitosan sulfate nanoparticles for protection and release of basic fibroblast growth factor.
Yi-Cheng Ho (2010)
Drug permeation through human skin: Theory and invitro experimental measurement
A. Michaels (1975)
Cancer nanotechnology: opportunities and challenges
M. Ferrari (2005)
Transfer of gold nanoparticles from the water column to the estuarine food web.
J. Ferry (2009)
Prostate-Specific Membrane Antigen Targeted Gold Nanoparticles for Theranostics of Prostate Cancer.
J. Mangadlao (2018)
Development and evaluation of finasteride loaded ethosomes for targeting to the pilosebaceous unit
V. Wilson (2018)
Nanoencapsulation of rice bran oil increases its protective effects against UVB radiation-induced skin injury in mice.
L. A. Rigo (2015)
Comparison of large unilamellar vesicles prepared by a petroleum ether vaporization method with multilamellar vesicles: ESR, diffusion and entrapment analyses.
H. Schieren (1978)
Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, α‐ and β‐amyrin, in a mouse model of colitis
C. E. Vitor (2009)
Phase behavior of aqueous systems of monoglycerides
E. S. Lutton (1965)
Polysaccharide-Based Nanoparticles for Controlled Release Formulations
A. Martínez (2012)
Drug delivery and targeting, v, 77-107 Drug targeting
Hydrogel nanoparticles for drug delivery.
M. Dalby (2013)
Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies
A. M. Fahmy (2018)
Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response.
C. Reis (2008)
Vesicles of Non-ionic Surfactants ( Niosomes ) and Drug Delivery Potential
S. Biswal (2008)
Proniosomes: a novel drug carrier preparation.
C. Hu (2000)
Ufasomes Mediated Cutaneous Delivery of Dexamethasone: Formulation and Evaluation of Anti-Inflammatory Activity by Carrageenin-Induced Rat Paw Edema Model
Rajkamal Mittal (2013)
Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin.
A. Chauhan (2003)
Nanoparticle-based theranostic agents.
J. Xie (2010)
Mechanisms of nanotoxicity: generation of reactive oxygen species.
P. Fu (2014)
Proliposomes: a novel solution to an old problem.
N. Payne (1986)
Application of gold nanoparticles for improved drug efficiency
K. Shittu (2017)
Hormonal therapy of cancer.
A. Segaloff (1959)
Advanced materials and processing for drug delivery: the past and the future.
Y. Zhang (2013)
Resveratrol and cancer: Challenges for clinical translation.
Chandra K Singh (2015)
Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation.
T. Ahmed (2016)
Formulation and In Vitro Evaluation of Ufasomes for Dermal Administration of Methotrexate
A. Sharma (2012)
Drug carriers for oral delivery of peptides and proteins: accomplishments and future perspectives.
Catarina P Reis (2013)
Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
Y. Liu (2011)
The effect of surface functionality on cellular trafficking of dendrimers.
Omathanu P Perumal (2008)
Magnetic Nanoparticles: Surface Effects and Properties Related to Biomedicine Applications
B. Issa (2013)
Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and X-ray-contrast-imaging studies.
Vijaya Kattumuri (2007)
Resveratrol nanoparticle system improves dissolution properties and enhances the hepatoprotective effect of resveratrol through antioxidant and anti-inflammatory pathways.
Chiang-Wen Lee (2012)
Gelation Factors of Pectin for Development of a Powder Form of Gel, Dry Jelly, as a Novel Dosage Form.
Yukari Kakino (2017)
Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy
G. Oberdörster (2005)
Broad overview of engineering of functional nanosystems for skin delivery.
Ana Henriques Mota (2017)
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
A. Klibanov (1990)
Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin
X. Peng (2015)
Hollow Magnetic Iron Oxide Nanoparticles as Sodium Meclofenamate Drug Delivery Systems
Vargas-González Brigido Alan (2016)
Application of design of experiments for formulation development and mechanistic evaluation of iontophoretic tacrine hydrochloride delivery
N. Patel (2016)
The performance of nanocarriers for transmucosal drug delivery
N. Csaba (2006)
Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity.
K. Raza (2013)
Promise and peril in nanomedicine: the challenges and needs for integrated systems biology approaches to define health risk
S. Halappanavar (2018)
CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors
K. Ahmed (2016)
Toxicity Assessment of Iron Oxide Nanoparticles in Zebrafish (Danio rerio) Early Life Stages
Xiaoshan Zhu (2012)
Preparation of liposomes using an improved supercritical reverse phase evaporation method.
K. Otake (2006)
Endothelial barriers: from hypothetical pores to membrane proteins.
J. A. Firth (2002)
Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells.
V. Sanna (2011)
Development and characterization of two nano-structured systems for topical application of flavanones isolated from Eysenhardtia platycarpa.
Valeri Domínguez-Villegas (2014)
Bile Salt Stabilized Vesicles (Bilosomes): A Novel Nano-Pharmaceutical Design for Oral Delivery of Proteins and Peptides.
J. Ahmad (2017)
Enhanced skin deposition and delivery of voriconazole using ethosomal preparations
W. Faisal (2018)
Characterization of single-core magnetite nanoparticles for magnetic imaging by SQUID relaxometry.
N. Adolphi (2010)
Liposomes: Targeted and Controlled Delivery System
T. Goyal (2014)
Diverse Applications of Nanomedicine
B. Pelaz (2017)
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
Sarbari Acharya (2011)
Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide
Y. Chen (2006)
In vitro skin permeation of nicotine from proliposomes
B. Hwang (1997)
Surface activity and safety of deamidated zein peptides
Lijuan Zhou (2018)
Doxil®--the first FDA-approved nano-drug: lessons learned.
Y. Barenholz (2012)
Dendrimers as drug carriers: applications in different routes of drug administration.
Y. Cheng (2008)
Plectranthus madagascariensis phytosomes : formulation optimization
Diogo Matias (2015)
Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities
I. Tabas (2013)
Nanodelivery systems based on mucoadhesive polymer coated solid lipid nanoparticles to improve the oral intake of food curcumin
P. Ramalingam (2016)
The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice.
M. N. Azmin (1985)
The immunology of asthma
B. Lambrecht (2014)
Questions and answers on Guideline on the environmental risk assessment of medicinal products for human use
London Uk (2011)
61 Natural products, v, 45
Polymeric Nanoparticles 337
L. Li (2005)
Biologically synthesized green silver nanoparticles from leaf extract of Vitex negundo L. induce growth-inhibitory effect on human colon cancer cell line HCT15
D. Prabhu (2013)
Effects of waterborne nano-iron on medaka (Oryzias latipes): antioxidant enzymatic activity, lipid peroxidation and histopathology.
H. Li (2009)
Natural Polymer Drug Delivery Systems: Nanoparticles, Plants, and Algae
Saurabh Bhatia (2016)
More than Just Size: Challenges and Opportunities of Hybrid Dendritic Nanocarriers.
G. N. Rimondino (2017)
Dendrimer Nanovectors for SiRNA Delivery.
Xiaoxuan Liu (2016)
Drug Delivery System in Nano Greens
M. Padmavathi (2013)
Fatty acid vesicles
K. Morigaki (2007)
Development and characterization of a nano-scale contrast agent.
Brian E. Oeffinger (2004)
Introduction to metallic nanoparticles
V. Mody (2010)
Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment.
A. Ahad (2013)
Optimized PLGA nanoparticle platform for orally dosed trans-resveratrol with enhanced bioavailability potential
Gurinder Singh (2014)
Antioxidant effects of quercetin and catechin encapsulated into PLGA nanoparticles
H. Pool (2012)
Novel Resveratrol and 5-Fluorouracil Coencapsulated in PEGylated Nanoliposomes Improve Chemotherapeutic Efficacy of Combination against Head and Neck Squamous Cell Carcinoma
A. Mohan (2014)
Formulation and in vitro evaluation of berberine containing liposome optimized by 32 full factorial designs
G. Sailor (2015)
Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes.
J. López-Pinto (2005)
Water-soluble dendrimer-poly(ethylene glycol) starlike conjugates as potential drug carriers
Mingjun Liu (1999)
Helical microtubules of graphitic carbon
S. Iijima (1991)
Vesicles as a tool for transdermal and dermal delivery.
P. Honeywell-Nguyen (2005)
Evaluation of metal nanoparticles for drug delivery systems
O. Adeyemi (2015)
Solamargine triggers cellular necrosis selectively in different types of human melanoma cancer cells through extrinsic lysosomal mitochondrial death pathway
Sana S. Al Sinani (2016)
Penetration enhancement of ibuprofen from supersaturated solutions through human skin.
M. Iervolino (2001)
Abraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gp
Minzhi Zhao (2015)
Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
Andreia Granja (2016)
The permeability barrier in mammalian epidermis
P. Elias (1975)
Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery.
V. Labhasetwar (2005)
Ethosomes of Phenylethyl Resorcinol as Vesicular Delivery System for Skin Lightening Applications
T. Limsuwan (2017)
Lipophilic drug derivatives in liposomes
Monica Gulati (1998)
Suppression of macrophage inflammatory responses by PPARs
P. Henson (2003)
Current methods for attaching targeting ligands to liposomes and nanoparticles.
Leila Nobs (2004)
Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes.
N. Dayan (2000)
Transfollicular delivery takes root: the future for vaccine design?
S. Hansen (2014)
Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions
N. Stone (2016)
Graphene Oxide-Gallic Acid Nanodelivery System for Cancer Therapy
Dena Dorniani (2016)
The influence of particle size of liposomes on the deposition of drug into skin
J. D. Plessis (1994)
Enhanced transdermal delivery of luteolin via non-ionic surfactant-based vesicle: quality evaluation and anti-arthritic assessment
L. Abidin (2016)
Single walled carbon nanotube reactivity and cytotoxicity following extended aqueous exposure.
Barbara J. Panessa-Warren (2009)
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
G. Oberdörster (2005)
A Predictive Algorithm for Skin Permeability: The Effects of Molecular Size and Hydrogen Bond Activity
R. Potts (2004)
DOE Optimization of Nano-based Carrier of Pregabalin as Hydrogel: New Therapeutic & Chemometric Approaches for Controlled Drug Delivery Systems
Mona G. Arafa (2017)
Receptor Crosslinking: A General Method to Trigger Internalization and Lysosomal Targeting of Therapeutic Receptor:Ligand Complexes
P. R. Moody (2015)
pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission.
T. Zhang (2011)
The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis.
D. Emerich (2006)
Sphingosomes for enhanced drug delivery
エス． ウェブ，ミューライ (1995)
In situ precipitation: a novel cytochemical technique for visualization of permeability pathways in mammalian stratum corneum.
M. Nemanic (1980)
Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles.
M. Loebinger (2009)
Effect of supersaturation on membrane transport: 2. Piroxicam
M. Pellett (1994)
Nanopharmaceutical Approach for Enhanced Anti-cancer Activity of Betulinic Acid in Lung-cancer Treatment via Activation of PARP: Interaction with DNA as a Target
J. Das (2016)
Evaluation of transdermal salidroside delivery using niosomes via in vitro cellular uptake.
Yongtai Zhang (2015)
Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy.
H. Chen (2008)
Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy
Hsin-I Chang (2012)
Supersaturated solutions evaluated with an in vitro stratum corneum tape stripping technique
M. Pellett (1997)
Optimizing novel implant formulations for the prolonged release of biopharmaceuticals using in vitro and in vivo imaging techniques.
S. Beyer (2016)
Biopharmaceutic classification of drugs revisited.
Chrysa Daousani (2016)
The emerging nanomedicines landscape
V Wagner (2006)
62 Vesicular carriers, v
V L Vergaro
Willie E. Bawarski (2008)
Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin.
M. Lopes (2016)
Nanopharmaceuticals : An Overview
A. Gaur (2008)
Nanoparticles for cancer therapy and diagnosis
Y. Fukumori (2006)
Application of Nanotechnology in Phytochemical Research
S. Sarker (2017)
Solid Lipid Nanoparticles of Albendazole for Enhancing Cellular Uptake and Cytotoxicity against U-87 MG Glioma Cell Lines
Gregory Marslin (2017)
Nanotherapeutics in the EU: an overview on current state and future directions
A. Hafner (2014)
PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture
Humberto H Lara (2010)
PAMAM Dendrimers Cross the Blood–Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice
Bhairavi Srinageshwar (2017)
PLGA nanoparticles loaded with etoposide and quercetin dihydrate individually: in vitro cell line study to ensure advantage of combination therapy
Smita S. Pimple (2012)
Lipid nanocapsules: a new platform for nanomedicine.
N. Huynh (2009)
Nanoparticle-based drug delivery to the vagina: a review.
Laura M Ensign (2014)
Anti-Cancer Potential of Boswellic Acid: A Mini Review
P. Garg (2015)
SEM Imaging Predicts Quality of Niosomes from Maltodextrin-Based Proniosomes
A. Blazek-Welsh (2004)
Approaches in Polymeric Nanoparticles for Vaginal Drug Delivery: A Review of the State of the Art
G. Leyva-Gómez (2018)
Nanosuspensions technology in drug delivery
R Dhanapal (2012)
Sphingosomes a novel approach to vesicular drug delivery
S. Saraf (2011)
Fate of engineered nanoparticles: Implications in the environment
A. D. Dwivedi (2015)
In Vitro/In Vivo Toxicity Evaluation and Quantification of Iron Oxide Nanoparticles
Ujwal S. Patil (2015)
Nanodrugs: pharmacokinetics and safety
S. Onoue (2014)
Healing sound: the use of ultrasound in drug delivery and other therapeutic applications
S. Mitragotri (2005)
Sorbitan Monopalmitate-Based Proniosomes for Transdermal Delivery of Chlorpheniramine Maleate
J. Varshosaz (2005)
Niosomes in sustained and targeted drug delivery: some recent advances
A. Azeem (2009)
Xiaoyun Lu (2011)
Damnacanthal is a potent inducer of apoptosis with anticancer activity by stimulating p53 and p21 genes in MCF-7 breast cancer cells
Muhammad Yusran Abdul Aziz (2014)
Mathematical modelling of magnetically targeted drug delivery
A. Grief (2005)
Preparation and characterisation of water-soluble phytosterol nanodispersions
Wai Fun Leong (2011)
PEGylated polymers for medicine: from conjugation to self-assembled systems.
Maisie J. Joralemon (2010)
Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases
S. Feng (2003)
Near infrared laser-tissue welding using nanoshells as an exogenous absorber.
A. Gobin (2005)
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: development, characterization and in vitro evaluation of their antitumoral efficacy.
D. Hernán Pérez de la Ossa (2012)
Skin microporation: strategies to enhance and expand transdermal drug delivery
S. A. Giannos (2014)
Curcumin and genistein coloaded nanostructured lipid carriers: in vitro digestion and antiprostate cancer activity.
N. P. Aditya (2013)
Preclinical characterisation of NSAIDs in ultradeformable carriers or conventional topical gels.
G. Cevc (2008)
Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles.
Houli Li (2009)
Inhalation of nanoparticle-based drug for lung cancer treatment: Advantages and challenges
Wing-Hin Lee (2015)
Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid
Kanika Madaan (2016)
Lipid-mediated gene delivery to the skin.
B. Geusens (2011)
Preparation of highly stable oligo(ethylene glycol) derivatives-functionalized gold nanoparticles and their application in LSPR-based detection of PSA/ACT complex.
C. Cao (2007)
Silymarin: an insight to its formulation and analytical prospects
U. Ahmad (2015)
Epigallocatechin-3-Gallate Inhibits IGF-I-Stimulated Lung Cancer Angiogenesis through Downregulation of HIF-1α and VEGF Expression
X. Li (2013)
Improvement in physicochemical parameters of DPPC liposomes and increase in skin permeation of aciclovir and minoxidil by the addition of cationic polymers.
A. Hasanovic (2010)
Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery.
G. Cevc (1996)
Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier
P. Lockman (2002)
Molecular Targeting of Alzheimer's Amyloid Plaques for Contrast-Enhanced Magnetic Resonance Imaging
J. Poduslo (2002)
Modifying the Surface Properties of Superparamagnetic Iron Oxide Nanoparticles through A Sol−Gel Approach
Y. Lu (2002)
Polymersomes Spanning from Nano- to Microscales: Advanced Vehicles for Controlled Drug Delivery and Robust Vesicles for Virus and Cell Mimicking
F. Meng (2011)
Anticancer Activity of Curcumin-Loaded PLGA Nanoparticles on PC3 Prostate Cancer Cells
Seyed Saeed Azandeh (2017)
Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system
T. Neuberger (2005)
Formulation and optimization of nano-sized ethosomes for enhanced transdermal delivery of cromolyn sodium
R. Rakesh (2012)
Molecular targeting of liposomal nanoparticles to tumor microenvironment
G. Zhao (2013)
Biomimetics in drug delivery systems: A critical review
M. Sheikhpour (2017)
Nanomedicines for back of the eye drug delivery, gene delivery, and imaging
U. Kompella (2013)
A novel approach to arthritis treatment based on resveratrol and curcumin co-encapsulated in lipid-core nanocapsules: In vivo studies.
K. Coradini (2015)
Nanoencapsulation of ABT-737 and camptothecin enhances their clinical potential through synergistic antitumor effects and reduction of systemic toxicity
D. Schmid (2014)
Liposomal drug delivery systems: from concept to clinical applications.
T. Allen (2013)
Nanoparticles as drug delivery systems.
A. Z. Wilczewska (2012)
Antiproliferative activity of abietane diterpenoids against human tumor cells.
O. Burmistrova (2013)
Development and ex vivo evaluation of 5-aminolevulinic acid-loaded niosomal formulations for topical photodynamic therapy.
M. Bragagni (2015)
Thematic review series: Skin Lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis Published, JLR Papers in Press, September 13, 2007.
K. Feingold (2007)
Resveratrol nanoformulation for cancer prevention and therapy.
I. A. Siddiqui (2015)
“Smart” Drug Carriers: PEGylated TATp-Modified pH-Sensitive Liposomes
A. Kale (2007)
Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDS1
Huanyu Dou (2009)
Vesicular systems for delivering conventional small organic molecules and larger macromolecules to and through human skin.
G. E. El Maghraby (2009)
Ethosomes: versatile vesicular carriers for efficient transdermal delivery of therapeutic agents
Vikas Pandey (2015)
Preparation and evaluation of lidocaine hydrochloride-loaded TAT-conjugated polymeric liposomes for transdermal delivery.
Y. Wang (2013)
Single-walled carbon nanotubes exhibit strong antimicrobial activity.
S. Kang (2007)
Future of the transdermal drug delivery market – have we barely touched the surface?
A. Watkinson (2016)
Glycan variation and evolution in the eukaryotes.
A. Corfield (2015)
Pharmaceutically versatile sulfated polysaccharide based bionano platforms.
S. Raveendran (2013)
Toxicokinetics and tissue distribution of cadmium-based Quantum Dots in the marine mussel Mytilus galloprovincialis.
T. Rocha (2015)
Cadmium telluride quantum dot nanoparticle cytotoxicity and effects on model immune responses to Pseudomonas aeruginosa
K. Nguyen (2013)
Effects of plant stanol esters on serum cholesterol concentrations, relative markers of cholesterol metabolism and endothelial function in type 1 diabetes.
M. Hallikainen (2008)
Biological and therapeutic activities, and anticancer properties of curcumin.
D. Perrone (2015)
Basic Principles of Liposomes for Drug Use
G. Martin (1992)
Solid lipid nanoparticles as oral delivery systems of phenolic compounds: Overcoming pharmacokinetic limitations for nutraceutical applications
Sara Nunes (2017)
Encapsulation of honokiol into self-assembled pectin nanoparticles for drug delivery to HepG2 cells.
Y. Zhang (2015)
Method for Comparing Percutaneous Absorption of Steroids
A. W. Mckenzie (1962)
Improved oral delivery of valsartan from maltodextrin based proniosome powders
Alekhya Gurrapu (2012)
Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies.
M. Foldvari (1990)
Pharmacokinetics of a paclitaxel-loaded low molecular weight heparin-all-trans-retinoid acid conjugate ternary nanoparticulate drug delivery system.
L. Hou (2012)
Nanoparticles for drug delivery in cancer treatment.
B. Haley (2008)
Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals.
C. Li (2015)
Improved in vitro and in vivo collagen biosynthesis by asiaticoside-loaded ultradeformable vesicles.
D. Paolino (2012)
Drug delivery applications with ethosomes.
D. Ainbinder (2010)
Integrative approach in prevention and therapy of basal cellular carcinoma by association of three actives loaded into lipid nanocarriers.
G. Badea (2015)
Trans-resveratrol loaded chitosan nanoparticles modified with biotin and avidin to target hepatic carcinoma.
L. Bu (2013)
Nanoethosomes for Dermal Delivery of Lidocaine.
Soraya Babaie (2015)
Vesicles and Liposomes: A Self-Assembly Principle Beyond Lipids†
M. Antonietti (2003)
Superior anticancer efficacy of curcumin-loaded nanoparticles against lung cancer.
Haitao Yin (2013)
Structural and biological mimicry of protein surface recognition by alpha/beta-peptide foldamers
W S Horne (2009)
Inhaled nano- and microparticles for drug delivery
I. ElSherbiny (2015)
Grassroots Innovation: A Promising Innovation Paradigm for Pharmaceutical Companies
Ulrich A. K. Betz (2014)
Nano-niosomes in drug, vaccine and gene delivery: a rapid overview
A. Pardakhty (2013)
Epaxal®: a virosomal vaccine to prevent hepatitis A infection
P. Bovier (2008)
Transdermal absorption enhancement of papain loaded in elastic niosomes incorporated in gel for scar treatment.
A. Manosroi (2013)
Current status and future potential of transdermal drug delivery
M. Prausnitz (2004)
The Application of Fluorescent Quantum Dots to Confocal, Multiphoton, and Electron Microscopic Imaging
T. Deerinck (2008)
Antibody-modified liposomes for cancer chemotherapy.
V. Torchilin (2008)
Natural product-based nanomedicine: recent advances and issues
R. Watkins (2015)
Stability of citrate, PVP, and PEG coated silver nanoparticles in ecotoxicology media.
M. Tejamaya (2012)
Immune resolution mechanisms in inflammatory arthritis
M. Perretti (2017)
Drug discovery in pharmaceutical industry: productivity challenges and trends.
I. Khanna (2012)
Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.
J. Holash (1999)
Proniosome based transdermal delivery of levonorgestrel for effective contraception.
B. Vora (1998)
Nanoparticle-based therapeutics in humans: a survey
R Bawa (2008)
Disposal by flushing of certain unused medicines: what you should know
Chemical Composition and Biological Activity of the Essential Oil of Origanum vulgare ssp. hirtum from Different Areas in the Southern Apennines (Italy)
E. Mancini (2014)
Evaluation of constant current alternating current iontophoresis for transdermal drug delivery.
G. Yan (2005)
Effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of guinea pigs in vitro
Y. Yokomizo (1996)
Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
Saumendu Deb Roy (1996)
Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel.
J. Khandare (2006)
Combinatorial approach in the design of multifunctional polymeric nano-delivery systems for cancer therapy.
A. Singh (2014)
Transdermal drug delivery: from micro to nano.
Carla Pegoraro (2012)
Ion-pair formation as a strategy to enhance topical delivery of salicylic acid.
S. A. Megwa (2000)
Involvement of the Kinin‐generating Cascade in Enhanced Vascular Permeability in Tumor Tissue
Yasuhiro Matsumura (1988)
Bilosomes Based Drug Delivery System
Ramchandra N. Chilkwar (2015)
Accumulation and elimination of iron oxide nanomaterials in zebrafish (Danio rerio) upon chronic aqueous exposure.
Y. Zhang (2015)
The skin: a pathway for systemic treatment with patches and lipid-based agent carriers
G. Cevc (1996)
Nanotoxicology and nanomedicine: making hard decisions.
I. Linkov (2008)
Progress in Nanomedicine: Approved and Investigational Nanodrugs.
C. Ventola (2017)
Sphingomyelin/cholesterol liposomal vincristine: a new formulation for an old drug
L. Boehlke (2006)
Preparation and characterization of liposomes as therapeutic delivery systems: a review.
S. Vemuri (1995)
Liposomes for Drug Delivery
Durgavati Yadav (2017)
Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system
S. Zhang (2016)
A Review of the Structure, Preparation, and Application of NLCs, PNPs, and PLNs
Qianwen Li (2017)
Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles.
Tzu-Hui Wu (2008)
Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.
T. Loftsson (1996)
Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression
N. Puvvada (2015)
Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin.
M. Manconi (2006)
A targeted drug delivery system based on dopamine functionalized nano graphene oxide
E. Masoudipour (2017)
Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer.
T. Dutta (2007)
Quantum dots in biology and medicine
R. E. Bailey (2004)
Stabilized terbutaline submicron drug aerosol for deep lungs deposition: drug assay, pulmonokinetics and biodistribution by UHPLC/ESI-q-TOF-MS method.
Md Faiyazuddin (2012)
PREPARATION AND IN-VITRO EVALUATION OF DICLOFENAC SODIUM NIOSOMAL FORMULATIONS
Marwa Helmy Abedullahh (2013)
Crossing cellular barriers using dendrimer nanotechnologies.
Mohammad Najlah (2006)
Toxicity and Environmental Risks of Nanomaterials : Challenges and Future Needs
P. P. Latha (2016)
Smaller is not always better: nanotechnology yields nanotoxicology.
H. Kipen (2005)
Preparation of transfersomes encapsulating sildenafil aimed for transdermal drug delivery: Plackett–Burman design and characterization
T. Ahmed (2015)
A biotechnological perspective on the application of iron oxide magnetic colloids modified with polysaccharides.
Ana M.G.C. Dias (2011)
Preparation of coenzyme Q10 liposomes using supercritical anti-solvent technique
Fei Xia (2012)
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective.
J. I. Hare (2017)
Synthesis and evaluation of a glutamic acid-modified hPAMAM complex as a promising versatile gene carrier
M. Hemmati (2016)
Recent advances in polymeric micelles for anti-cancer drug delivery.
Swati Biswas (2016)
Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential
M. Immordino (2006)
NIOSOMES – CHALLENGE IN PREPARATION FOR PHARMACEUTICAL SCIENTIST
RAJESH Z. MUJORIYAA (2011)
Fabrication of genistein-loaded biodegradable TPGS-b-PCL nanoparticles for improved therapeutic effects in cervical cancer cells
Hongling Zhang (2015)
Study of artemisinin nanocapsules as anticancer drug delivery systems.
Youfang Chen (2009)
Temperature-sensitive hydrogels with SiO2-Au nanoshells for controlled drug delivery.
M. Bikram (2007)
Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration
A. Amrite (2008)
Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos.
Ofek Bar-Ilan (2009)
Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery.
N. Kohler (2006)
Development of Ethosomes Containing Mycophenolic Acid
T. Limsuwan (2012)
PEGylated nanoparticles for biological and pharmaceutical applications.
H. Otsuka (2003)
Anti-inflammatory effect of α, β-Amyrin, a pentacyclic triterpene from Protium heptaphyllum in rat model of acute periodontitis
S. A. Holanda Pinto (2007)
Inflammation and wound healing.
T. Oberyszyn (2007)
Single bilayer liposomes prepared without sonication.
S. Batzri (1973)
Formulation and characterization of Phospholipon 90 G and tween 80 based transfersomes for transdermal delivery of eprosartan mesylate
A. Ahad (2018)
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Y. Matsumura (1986)
In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
A. Anitha (2014)
Environmental risk assessment, vi
Proteosome inhibition mediates p53 reactivation and anticancer activity of 6-gingerol in cervical cancer cells
N Rastogi (2015)
Dendrimers: properties and application
K Barbara (2001)
A bibliometric investigation of research performance in emerging nanobiopharmaceuticals
Kaihua Chen (2011)
Overview of nano-drugs characteristics for clinical application: the journey from the entry to the exit point
Tanima Bose (2014)
In vitro skin permeation of estradiol from various proniosome formulations.
J. Fang (2001)
Introduction of Nanotechnology in Herbal Drugs and Nutraceutical: A Review
S. Gopi (2016)
Dendrimers as anti-inflammatory agents
P. K. Avti (2013)
Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.
Emily Gullotti (2009)
Preparation and characterization of quercetin nanocrystals.
N. G. Sahoo (2011)
Global Cancer Incidence and Mortality Rates and Trends—An Update
L. Torre (2015)
Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization.
N. Morsi (2014)
Preparation of Curcumin-Loaded Liposomes and Evaluation of Their Skin Permeation and Pharmacodynamics
Y. Chen (2012)
Polyelectrolyte biomaterial interactions provide nanoparticulate carrier for oral insulin delivery.
C. Reis (2008)
Copper nanoparticles/compounds impact agronomic and physiological parameters in cilantro (Coriandrum sativum).
Nubia Zuverza-Mena (2015)
Nanopharmaceuticals: Tiny challenges for the environmental risk assessment of pharmaceuticals.
Silvia Berkner (2016)
Bionanotechnology progress and advances.
W. Chan (2006)
Carbon nanotubes as drug delivery nanocapsules
Tamsyn A. Hilder (2008)
Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
M. Mokhtar (2008)
Development of novel fusogenic vesosomes for transcutaneous immunization.
V. Mishra (2006)
Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development
T. Wong (2014)
Current application of phytocompound-based nanocosmeceuticals for beauty and skin therapy
P. Ganesan (2016)
Development of Biodegradable Nanoparticles for Oral Delivery of Ellagic Acid and Evaluation of Their Antioxidant Efficacy Against Cyclosporine A-Induced Nephrotoxicity in Rats
K. Sonaje (2006)
Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol
Deepti Pandita (2014)
Human skin sandwich for assessing shunt route penetration during passive and iontophoretic drug and liposome delivery.
Ebtessam A. Essa (2002)
Enhanced leukemia cell detection using a novel magnetic needle and nanoparticles.
Jason E. Jaetao (2009)
Penetration of tamoxifen citrate loaded ethosomes and liposomes across human skin: a comparative study with confocal laser scanning microscopy.
K. Sarwa (2014)
Paclitaxel-loaded PEGylated nanocapsules of perfluorooctyl bromide as theranostic agents.
Tanguy Boissenot (2016)
Biocompatibility and therapeutic evaluation of magnetic liposomes designed for self-controlled cancer hyperthermia and chemotherapy.
Manashjit Gogoi (2017)
Thymoquinone in liposomes: a study of loading efficiency and biological activity towards breast cancer
F. Odeh (2012)
Approaches for breaking the barriers of drug permeation through transdermal drug delivery.
A. Alexander (2012)
Nanocrystal technology, drug delivery and clinical applications
Jens-Uwe A. H. Junghanns (2008)
Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease
A. García-Lafuente (2009)
Liposome application: problems and prospects
Y. Barenholz (2001)
Current and emerging lipid-based systems for transdermal drug delivery.
S. K. Singla (2015)
Curcumin-ER Prolonged Subcutaneous Delivery for the Treatment of Non-Small Cell Lung Cancer.
A. Ranjan (2016)
Natural Nanoparticles: A Particular Matter Inspired by Nature
S. Griffin (2017)
Anticancer activity and molecular mechanism of resveratrol-bovine serum albumin nanoparticles on subcutaneously implanted human primary ovarian carcinoma cells in nude mice.
Li-Yuan Guo (2010)
Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery.
Hui-Ting Chen (2004)
Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.
F. Muggia (1997)
Design and characterization of lisinopril-loaded superparamagnetic nanoparticles as a new contrast agent for in vitro, in vivo MRI imaging, diagnose the tumors and drug delivery system
Sajjad Abbasi Pour (2017)
Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers.
C. Lin (2017)
Elegant pH-Responsive Nanovehicle for Drug Delivery Based on Triazine Dendrimer Modified Magnetic Nanoparticles.
Amir Landarani-Isfahani (2017)
Formulation Optimization and In-vitro and In-vivo Evaluation of Lornoxicam Ethosomal Gels with Penetration Enhancers.
KeKe Li (2018)
Protective effect of methylsulfonylmethane in caerulein‐induced acute pancreatitis and associated lung injury in mice
Ranjith Kumar Velusamy (2018)
Semiconductor quantum dots as fluorescent probes for in vitro and in vivo bio-molecular and cellular imaging
S. B. Rizvi (2010)
Production and Characterization of Cosmetic Nanoemulsions Containing Opuntia ficus-indica (L.) Mill Extract as Moisturizing Agent
Renato César de Azevedo Ribeiro (2015)
Nanotechnology for the delivery of phytochemicals in cancer therapy.
J. Xie (2016)
Thymoquinone-Loaded Nanostructured Lipid Carrier Exhibited Cytotoxicity towards Breast Cancer Cell Lines (MDA-MB-231 and MCF-7) and Cervical Cancer Cell Lines (HeLa and SiHa)
W. K. Ng (2015)
Bioavailability of phytochemicals and its enhancement by drug delivery systems.
F. Aqil (2013)
Biomolecular coronas in invertebrate species: Implications in the environmental impact of nanoparticles
L. Canesi (2017)
Food hydrocolloids applications of chitosan nanoparticles to enhance absorption and bioavailability of tea polyphenols : a review. Food Hydrocoll
J Liang (2017)
Nanotechnology based chemopreventive approaches to improve the oral delivery of Silymarin in liver cancer
U Ahmad (2015)
Nanoparticles for systemic medicines and imaging agents
M E Davis (2006)
Evaluating the Impact of Treatment Effectiveness and Side Effects in Prescribing Choices
Tat Y. Chan (2014)
Test no. 40: ecotoxicology and environmental fate of manufactured nanomaterials-Expert meeting report
Dual-Mode Imaging-Guided Synergistic Chemo- and Magnetohyperthermia Therapy in a Versatile Nanoplatform To Eliminate Cancer Stem Cells.
Jinglong Tang (2017)
Niosomes as vesicular carriers for delivery of proteins and biologicals
S. Shilpa (2011)
Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse Model
C. Destache (2016)
Test of a two-pathway model for small-solute exchange across the capillary wall.
B. Fu (1998)
Nanoparticles and cancer therapy: A concise review with emphasis on dendrimers
D. Bharali (2009)
Gold nanorods in photodynamic therapy, as hyperthermia agents, and in near-infrared optical imaging.
Wen-Shuo Kuo (2010)
DNA delivery for vaccination and therapeutics through the skin.
M. Foldvari (2006)
Synthesis, characterization and magnetic properties of nearly monodisperse CuCr2Se4 nanoparticles.
C. Lin (2010)
Design of Chitosan and Its Water Soluble Derivatives-Based Drug Carriers with Polyelectrolyte Complexes
Qing-Xi Wu (2014)
Preparation, Characterization and Evaluation of Sun Protective and Moisturizing Effects of Nanoliposomes Containing Safranal
S. Golmohammadzadeh (2011)
Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics
X. Michalet (2005)
Designing chitosan-dextran sulfate nanoparticles using charge ratios
Y. Chen (2008)
New aspects of nanopharmaceutical delivery systems.
P. D. Marcato (2008)
Nanoparticle-based vaginal drug delivery systems for HIV prevention
R. Mallipeddi (2010)
Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice.
M. L. Schipper (2009)
Polymersome Macromolecule Delivery across Intact Human Skin
Carla Pegoraro (2011)
Resistance to nanoparticle albumin-bound paclitaxel is mediated by ABCB1 in urothelial cancer cells
S. Vallo (2017)
Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy
S. Bisht (2007)
Today’s diverse nano-theranostic applications and tomorrow’s promises
T. Webster (2015)
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
F. Kratz (2008)
Nanodrugs: optimism for emerging trend of multidrug resistance
A. Khan (2012)
Drug-loaded carbon nanohorns: adsorption and release of dexamethasone in vitro.
T. Murakami (2004)
Biodistribution of intravenously administered amphiphilic beta-cyclodextrin nanospheres.
A. Géze (2007)
Ethosomes for enhanced skin delivery of griseofulvin.
J. Marto (2016)
Ethosomes and organogels for cutaneous administration of crocin
E. Esposito (2016)
Triple-functional albumin-based nanoparticles for combined chemotherapy and photodynamic therapy of pancreatic cancer with lymphatic metastases
Xinzhe Yu (2017)
Drug delivery routes in skin: a novel approach.
B. Barry (2002)
Drug Nanocrystals/Nanosuspensions for the Delivery of Poorly Soluble Drugs
R. Mueller (2006)
Ecotoxic effects of paclitaxel-loaded nanotherapeutics on freshwater algae, Raphidocelis subcapitata and Chlamydomonas reinhardtii
Yagmur Yegin (2017)
Design and Development of a Proniosomal Transdermal Drug Delivery System for Captopril
A. Gupta (2007)
Ecotoxicity and Toxicity of Nanomaterials with Potential for Wastewater Treatment Applications
V. Nogueira (2017)
Mechanisms of hormonal therapy resistance in breast cancer
S. Hayashi (2015)
Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells
Wanisa Punfa (2012)
Recent developments in novel drug delivery systems for wound healing
L. Pachuau (2015)
Polyamidoamine (PAMAM) Dendrimers Modified with Cathepsin-B Cleavable Oligopeptides for Enhanced Gene Delivery
S. Lee (2017)
Surface functionalisation of PLGA nanoparticles for gene silencing.
M. Ø. Andersen (2010)
Tumor-targeting, pH-responsive, and stable unimolecular micelles as drug nanocarriers for targeted cancer therapy.
Xiaoqiang Yang (2010)
Evaluation of Photoprotective Potential and Percutaneous Penetration by Photoacoustic Spectroscopy of the Schinus terebinthifolius Raddi Extract.
Milena Keller Bulla (2015)
Poly(ethylenimine) conjugated bioreducible dendrimer for efficient gene delivery.
Kihoon Nam (2015)
Recent Advances in Nanoparticle-Mediated Delivery of Anti-Inflammatory Phytocompounds
R. Conte (2017)
Synthesis and characterization of a multifunctional gold‐doxorubicin nanoparticle system for pH triggered intracellular anticancer drug release
Ganesh V. Khutale (2017)
Tuning the Magnetic Properties of Nanoparticles
Arati G. Kolhatkar (2013)
Resveratrol-loaded nanocapsules inhibit murine melanoma tumor growth.
Bruna Carletto (2016)
Nanopharmaceuticals to target antifilarials: a comprehensive review
M. Ali (2013)
Aspectos gerais em sistemas transdérmicos de liberação de fármacos General aspects in transdermal systems of drugs release
Toxic Potential of Materials at the Nanolevel
A. Nel (2006)
ANTICANCER ACTIVITY OF SILVER NANOBIOCONJUGATES SYNTHESISED FROM PIPER BETLE LEAVES EXTRACT AND ITS ACTIVE COMPOUND EUGENOL
R. Preethi (2016)
Cellular imaging in drug discovery
P. Lang (2006)
Mechanisms underlying the inhibitory actions of the pentacyclic triterpene alpha-amyrin in the mouse skin inflammation induced by phorbol ester 12-O-tetradecanoylphorbol-13-acetate.
R. Medeiros (2007)
Benzocaine loaded solid lipid nanoparticles: Formulation design, in vitro and in vivo evaluation of local anesthetic effect.
M. Basha (2015)
Lipid-based nano-delivery systems for skin delivery of drugs and bioactives
Susan Hua (2015)
Preparation and characterization of niosomes containing rifampicin for lung targeting.
C. Jain (1995)
Sertaconazole nitrate loaded nanovesicular systems for targeting skin fungal infection: In-vitro, ex-vivo and in-vivo evaluation.
M. Abd-El-latif (2017)